| 1 |
Yang H, Zhang K, Guo Y, Guo X, Hou K, Hou J, Luo Y, Liu J, Jia S. Gain-of-Function p53N236S Mutation Drives the Bypassing of HRas(V12)-Induced Cellular Senescence via PGC-1α. Int J Mol Sci 2023;24. [PMID: 36835200 DOI: 10.3390/ijms24043790] [Reference Citation Analysis]
|
| 2 |
Chiu HW, Hung SW, Chiu CF, Hong JR. A Mitochondrion-Targeting Protein (B2) Primes ROS/Nrf2-Mediated Stress Signals, Triggering Apoptosis and Necroptosis in Lung Cancer. Biomedicines 2023;11. [PMID: 36672696 DOI: 10.3390/biomedicines11010186] [Reference Citation Analysis]
|
| 3 |
Chen C, Wang K, Luo L. AuNPs and 2D functional nanomaterial-assisted SPR development for the cancer detection: a critical review. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00138-7] [Reference Citation Analysis]
|
| 4 |
Li Y, Azmi AS, Mohammad RM. Deregulated transcription factors and poor clinical outcomes in cancer patients. Semin Cancer Biol 2022;86:122-34. [PMID: 35940398 DOI: 10.1016/j.semcancer.2022.08.001] [Reference Citation Analysis]
|
| 5 |
Hoashi T, Kanda N, Saeki H. Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma. IJMS 2022;23:11968. [DOI: 10.3390/ijms231911968] [Reference Citation Analysis]
|
| 6 |
Langer HT, Mossakowski AA, Sule R, Gomes A, Baar K. Dominant-negative p53-overexpression in skeletal muscle induces cell death and fiber atrophy in rats. Cell Death Dis 2022;13:716. [PMID: 35977948 DOI: 10.1038/s41419-022-05160-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Liu J, Yu X, Chen H, Kaniskan HÜ, Xie L, Chen X, Jin J, Wei W. TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors. J Am Chem Soc 2022. [PMID: 35786952 DOI: 10.1021/jacs.2c04824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Wang Q, Zhang Y, Zhang E, Xing X, Chen Y, Nie K, Yuan H, Su M, Lang N. A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone. Front Oncol 2022;12:894696. [DOI: 10.3389/fonc.2022.894696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Biswas P, Datta C, Rathi P, Bhattacharjee A. Fatty acids and their lipid mediators in the induction of cellular apoptosis in cancer cells. Prostaglandins Other Lipid Mediat 2022;160:106637. [PMID: 35341977 DOI: 10.1016/j.prostaglandins.2022.106637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Nascente EP, Amorim RL, Fonseca-Alves CE, de Moura VMBD. Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions. Cancers (Basel) 2022;14:2727. [PMID: 35681707 DOI: 10.3390/cancers14112727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Weskamp P, Ufton D, Drysch M, Wagner JM, Dadras M, Lehnhardt M, Behr B, Wallner C. Risk Factors for Occurrence and Relapse of Soft Tissue Sarcoma. Cancers (Basel) 2022;14. [PMID: 35267581 DOI: 10.3390/cancers14051273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Chen X, Yin C, Liu Q, Liu J. Regulation Effect of miR-34a Expression on Radiosensitivity of Lung Adenocarcinoma Cells by Targeting Bcl-2 and CDK4/6 Signaling Pathways. JCT 2022;13:187-198. [DOI: 10.4236/jct.2022.134015] [Reference Citation Analysis]
|
| 13 |
Chen X, Yin C, Liu Q, Liu J. Regulation Effect of miR-34a Expression on Radiosensitivity of Lung Adenocarcinoma Cells by Targeting Bcl-2 and CDK4/6 Signaling Pathways. JCT 2022;12:187-198. [DOI: 10.4236/jct.2022.124015] [Reference Citation Analysis]
|
| 14 |
Xia YQ, Cheng JX, Liu YF, Li CH, Liu Y, Liu PF. Genome-wide integrated analysis reveals functions of lncRNA-miRNA-mRNA interactions in Atlantic salmon challenged by Aeromonas salmonicida. Genomics 2021:S0888-7543(21)00441-9. [PMID: 34933071 DOI: 10.1016/j.ygeno.2021.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Li J, Wang J, Su D, Nie X, Liu Y, Teng L, Pang J, Wu H, Liang Z, Sakai E. p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms. Gastroenterology Research and Practice 2021;2021:1-9. [DOI: 10.1155/2021/2510195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2021. [DOI: 10.1002/9781119730248.ch9] [Reference Citation Analysis]
|
| 17 |
Plachetzki DC, Pankey MS, MacManes MD, Lesser MP, Walker CW. The Genome of the Softshell Clam Mya arenaria and the Evolution of Apoptosis. Genome Biol Evol 2020;12:1681-93. [PMID: 32653903 DOI: 10.1093/gbe/evaa143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Hou JY, Zhou L, Li JL, Wang DP, Cao JM. Emerging roles of non-histone protein crotonylation in biomedicine. Cell Biosci 2021;11:101. [PMID: 34059135 DOI: 10.1186/s13578-021-00616-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Kressin M, Fietz D, Becker S, Strebhardt K. Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer. Cells 2021;10:1176. [PMID: 34065956 DOI: 10.3390/cells10051176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 20 |
Allmon E, Serafin J, Chen S, Simning D, Griffitt R, Bosker T, De Guise S, Sepúlveda MS. The influence of hypoxia on the cardiac transcriptomes of two estuarine species - C. variegatus and F. grandis. Comp Biochem Physiol Part D Genomics Proteomics 2021;39:100837. [PMID: 33892309 DOI: 10.1016/j.cbd.2021.100837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 21 |
Huang YS, Hsu WC, Lin CH, Lo SN, Cheng CN, Lin MS, Lee TW, Chang CH, Lan KL. Bi-Functional Radiotheranostics of 188Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells. Int J Mol Sci 2021;22:1902. [PMID: 33672989 DOI: 10.3390/ijms22041902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 22 |
Wu C, Cui Y, Liu X, Zhang F, Lu LY, Yu X. The RNF20/40 complex regulates p53-dependent gene transcription and mRNA splicing. J Mol Cell Biol 2020;12:113-24. [PMID: 31152661 DOI: 10.1093/jmcb/mjz045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Shashni B, Nagasaki Y. Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers. J Pers Med 2021;11:92. [PMID: 33540693 DOI: 10.3390/jpm11020092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Glykofridis IE, Knol JC, Balk JA, Westland D, Pham TV, Piersma SR, Lougheed SM, Derakhshan S, Veen P, Rooimans MA, van Mil SE, Böttger F, Poddighe PJ, van de Beek I, Drost J, Zwartkruis FJ, de Menezes RX, Meijers-Heijboer HE, Houweling AC, Jimenez CR, Wolthuis RM. Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells. Elife 2021;10:e61630. [PMID: 33459596 DOI: 10.7554/eLife.61630] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 25 |
Al Zouabi NN, Roberts CM, Lin ZP, Ratner ES. Flow Cytometric Analyses of p53-Mediated Cell Cycle Arrest and Apoptosis in Cancer Cells. Methods Mol Biol 2021;2255:43-53. [PMID: 34033093 DOI: 10.1007/978-1-0716-1162-3_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Popper H. Molecular Pathology of Lung Tumors. Pathology of Lung Disease 2021. [DOI: 10.1007/978-3-030-55743-0_19] [Reference Citation Analysis]
|
| 27 |
Wijethilake N, Meedeniya D, Chitraranjan C, Perera I, Islam M, Ren H. Glioma Survival Analysis Empowered With Data Engineering—A Survey. IEEE Access 2021;9:43168-91. [DOI: 10.1109/access.2021.3065965] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 28 |
Karimzadeh Z, Hasanzadeh M, Isildak I, Khalilzadeh B. Multiplex bioassaying of cancer proteins and biomacromolecules: Nanotechnological, structural and technical perspectives. Int J Biol Macromol 2020;165:3020-39. [PMID: 33122068 DOI: 10.1016/j.ijbiomac.2020.10.191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Song S, Lee JU, Kang J, Park KH, Sim SJ. Real-time monitoring of distinct binding kinetics of hot-spot mutant p53 protein in human cancer cells using an individual nanorod-based plasmonic biosensor. Sensors and Actuators B: Chemical 2020;322:128584. [DOI: 10.1016/j.snb.2020.128584] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 30 |
Wang CC, Wang CT, Chou WC, Kao CL, Tsai KL. Hyaluronic acid injection reduces inflammatory and apoptotic markers through modulation of AKT by repressing the oxidative status of neutrophils from osteoarthritic synovial fluid. Int J Biol Macromol 2020;165:2765-72. [PMID: 33736281 DOI: 10.1016/j.ijbiomac.2020.10.154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 31 |
Morita S, Suda T, Kishi Y, Iwasaki T, Hiraoka N, Nagayama I, Hoshi T, Abe S, Yagi K, Hasegawa G, Ikarashi T, Terai S. Synchronous Double Bile Duct Cancers with Distinct Genetic Features. Intern Med 2020;59:2129-34. [PMID: 32493852 DOI: 10.2169/internalmedicine.4613-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 32 |
Therachiyil L, Haroon J, Sahir F, Siveen KS, Uddin S, Kulinski M, Buddenkotte J, Steinhoff M, Krishnankutty R. Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin. Front Oncol 2020;10:1744. [PMID: 32984059 DOI: 10.3389/fonc.2020.01744] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 33 |
Tendler Y, Panshin A. Features of p53 protein distribution in the corneal epithelium and corneal tear film. Sci Rep 2020;10:10051. [PMID: 32572102 DOI: 10.1038/s41598-020-67206-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Istiqomah MA, Hasibuan PAZ, Sumaiyah S, Yusraini E, Oku H, Basyuni M. Anticancer Effects of Polyisoprenoid From Nypa fruticans Leaves by Controlling Expression of p53, EGFR, PI3K, AKT1, and mTOR Genes in Colon Cancer (WiDr) Cells. Natural Product Communications 2020;15:1934578X2091841. [DOI: 10.1177/1934578x20918412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 35 |
Hou J, Cao X, Cheng Y, Wang X. Roles of TP53 gene in the development of resistance to PI3K inhibitor resistances in CRISPR-Cas9-edited lung adenocarcinoma cells. Cell Biol Toxicol 2020;36:481-92. [PMID: 32239370 DOI: 10.1007/s10565-020-09523-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 36 |
Wu C, Yang P, Liu B, Tang Y. Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma? Onco Targets Ther 2020;13:2551-62. [PMID: 32273725 DOI: 10.2147/OTT.S232464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 37 |
Li Y, Jiang W, Li T, Li M, Li X, Zhang Z, Zhang S, Liu Y, Zhao W, Gu Y, Qi L, Ao L, Guo Z. Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma. J Transl Med 2020;18:25. [PMID: 31937321 DOI: 10.1186/s12967-019-02199-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Argyle DJ, Khanna C, Giancristofaro N. Tumor Biology and Metastasis. Withrow and MacEwen's Small Animal Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-59496-7.00002-5] [Reference Citation Analysis]
|
| 39 |
Ma N, Zhu L, Yang L, Cui Y, Zhan Y. Prognostic values of S100 family mRNA expression in ovarian cancer. Cancer Biomark 2019;25:67-78. [PMID: 31033462 DOI: 10.3233/CBM-182276] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 40 |
Liu L, Cao J, Zhao J, Li X, Suo Z, Li H. PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo. Onco Targets Ther 2019;12:9899-913. [PMID: 31819487 DOI: 10.2147/OTT.S226851] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 41 |
Guan XL, Zhang BC, Sun L. Japanese flounder pol-miR-3p-2 suppresses Edwardsiella tarda infection by regulation of autophagy via p53. Dev Comp Immunol 2020;103:103531. [PMID: 31668931 DOI: 10.1016/j.dci.2019.103531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Pellerano M, Naud-Martin D, Mahuteau-Betzer F, Morille M, Morris MC. Fluorescent Biosensor for Detection of the R248Q Aggregation-Prone Mutant of p53. Chembiochem 2019;20:605-13. [PMID: 30548750 DOI: 10.1002/cbic.201800531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Engin AB, Engin A. DNA damage checkpoint response to aflatoxin B1. Environmental Toxicology and Pharmacology 2019;65:90-6. [DOI: 10.1016/j.etap.2018.12.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 44 |
Noh D, Choi JG, Huh E, Oh MS. Tectorigenin, a Flavonoid-Based Compound of Leopard Lily Rhizome, Attenuates UV-B-Induced Apoptosis and Collagen Degradation by Inhibiting Oxidative Stress in Human Keratinocytes. Nutrients 2018;10:E1998. [PMID: 30562977 DOI: 10.3390/nu10121998] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 45 |
Bing Y, Wund Z, Abratte T, Borlle L, Kang S, Southard T, Hume KR. Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas. Cancer Cell Int 2018;18:192. [PMID: 30498397 DOI: 10.1186/s12935-018-0690-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 46 |
Fedorova O, Petukhov A, Daks A, Shuvalov O, Leonova T, Vasileva E, Aksenov N, Melino G, Barlev NA. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. Oncogene 2019;38:2108-22. [PMID: 30455429 DOI: 10.1038/s41388-018-0566-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 47 |
Hansen MJ, Feringa FM, Kobauri P, Szymanski W, Medema RH, Feringa BL. Photoactivation of MDM2 Inhibitors: Controlling Protein-Protein Interaction with Light. J Am Chem Soc 2018;140:13136-41. [PMID: 30284823 DOI: 10.1021/jacs.8b04870] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 48 |
Stukan AI, Porhanov VA, Bodnya VN, Chuhraj OY, Makarova YM, Elizbaryan IS. Molecular and genetic profile of head and neck squamous cell carcinoma. Med vestn Ûga Ross 2018;9:50-57. [DOI: 10.21886/2219-8075-2018-9-3-50-57] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 49 |
Suehara Y, Akaike K, Mukaihara K, Kurisaki-Arakawa A, Kubota D, Okubo T, Mitomi H, Mitani K, Takahashi M, Toda-Ishii M, Kim Y, Tanabe Y, Takagi T, Hayashi T, Mogushi K, Kaneko K, Yao T, Saito T. KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors. Oncotarget 2018;9:27016-26. [PMID: 29930747 DOI: 10.18632/oncotarget.25469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 50 |
Yi H, Yan X, Luo Q, Yuan L, Li B, Pan W, Zhang L, Chen H, Wang J, Zhang Y, Zhai Y, Qiu MZ, Yang DJ. A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma. J Exp Clin Cancer Res 2018;37:97. [PMID: 29716622 DOI: 10.1186/s13046-018-0765-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 51 |
Kopnin B. Genetic Events Responsible for Colorectal Tumorigenesis: Achievements and Challenges. Tumori 1993;79:235-43. [DOI: 10.1177/030089169307900401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 52 |
Fadl-allah E, Mahmoud M, Abd El-twab M, Helmey R. Aflatoxin B 1 induces chromosomal aberrations and 5S rDNA alterations in durum wheat. Journal of the Association of Arab Universities for Basic and Applied Sciences 2018;10:8-14. [DOI: 10.1016/j.jaubas.2011.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 53 |
Wang J, Bao A, Wang Q, Guo H, Zhang Y, Liang J, Kong W, Yao J, Zhang J. Sulfation can enhance antitumor activities of Artemisia sphaerocephala polysaccharide in vitro and vivo. International Journal of Biological Macromolecules 2018;107:502-11. [DOI: 10.1016/j.ijbiomac.2017.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 54 |
Kim J, Park SH, Do KH, Kim D, Moon Y. Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens. Oncotarget 2016;7:39627-39. [PMID: 27119350 DOI: 10.18632/oncotarget.8914] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 55 |
García-Barrado MJ, Blanco EJ, Iglesias-Osma MC, Carretero-Hernández M, Catalano-Iniesta L, Sanchez-Robledo V, Carretero M, Herrero JJ, Carrero S, Carretero J. Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas. Int J Mol Sci 2017;18:E2299. [PMID: 29104246 DOI: 10.3390/ijms18112299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Farhadi E, Safa M, Sharifi AM, Bashash D. PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-Myc. Anticancer Drugs 2017;28:51-8. [PMID: 27548348 DOI: 10.1097/CAD.0000000000000426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 57 |
Chiu HW, Su YC, Hong JR. Betanodavirus B2 protein triggers apoptosis and necroptosis in lung cancer cells that suppresses autophagy. Oncotarget 2017;8:94129-41. [PMID: 29212215 DOI: 10.18632/oncotarget.21588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 58 |
Berretta M, Cavaliere C, Alessandrini L, Stanzione B, Facchini G, Balestreri L, Perin T, Canzonieri V. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget. 2017;8:14192-14220. [PMID: 28077782 DOI: 10.18632/oncotarget.13929] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 59 |
Semczuk A, Gogacz M, Semczuk-Sikora A, Jóźwik M, Rechberger T. The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review. J Cancer 2017;8:2684-91. [PMID: 28928856 DOI: 10.7150/jca.19691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 60 |
Bhagavatula G, Rich MS, Young DL, Marin M, Fields S. A Massively Parallel Fluorescence Assay to Characterize the Effects of Synonymous Mutations on TP53 Expression. Mol Cancer Res 2017;15:1301-7. [PMID: 28652265 DOI: 10.1158/1541-7786.MCR-17-0245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 61 |
Li M, Wang D, Wang Y, Sun G, Song W, Zhang B, Borjigin B. Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia. Oncol Lett 2017;14:1484-90. [PMID: 28789369 DOI: 10.3892/ol.2017.6374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 62 |
Zielińska-Przyjemska M, Kaczmarek M, Krajka-Kuźniak V, Łuczak M, Baer-Dubowska W. The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines. Toxicol In Vitro 2017;43:69-75. [PMID: 28595835 DOI: 10.1016/j.tiv.2017.06.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 63 |
Chan TA, Hristov B, Powell SN. Radiation Biology for Radiation Oncologists. Clinical Radiation Oncology 2017. [DOI: 10.1002/9781119341154.ch2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 64 |
Kocsis J, Árokszállási A, András C, Balogh I, Béres E, Déri J, Peták I, Jánváry L, Horváth Z. Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion. J Gastrointest Oncol 2017;8:E32-8. [PMID: 28480077 DOI: 10.21037/jgo.2017.01.06] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 65 |
Dube B, Pandey A, Joshi G, Sawant K. Hydrophobically modified polyethylenimine-based ternary complexes for targeting brain tumor: stability, in vitro and in vivo studies. Artif Cells Nanomed Biotechnol 2017;45:1685-98. [PMID: 28278583 DOI: 10.1080/21691401.2017.1282497] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 66 |
Popper H. Molecular Pathology of Lung Tumors. Pathology of Lung Disease 2017. [DOI: 10.1007/978-3-662-50491-8_19] [Reference Citation Analysis]
|
| 67 |
Kamenova-nacheva M, Schröder M, Pasheva E, Slavchev I, Dimitrov V, Momekov G, Nikolova R, Shivachev B, Ugrinova I, Dobrikov GM. Synthesis of ferrocenylmethylidene and arylidene substituted camphane based compounds as potential anticancer agents. New J Chem 2017;41:9103-12. [DOI: 10.1039/c7nj00619e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Jayanthi VSPKSA, Das AB, Saxena U. Recent advances in biosensor development for the detection of cancer biomarkers. Biosens Bioelectron 2017;91:15-23. [PMID: 27984706 DOI: 10.1016/j.bios.2016.12.014] [Cited by in Crossref: 259] [Cited by in F6Publishing: 213] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 69 |
Brázdová M, Tichý V, Helma R, Bažantová P, Polášková A, Krejčí A, Petr M, Navrátilová L, Tichá O, Nejedlý K, Bennink ML, Subramaniam V, Bábková Z, Martínek T, Lexa M, Adámik M. p53 Specifically Binds Triplex DNA In Vitro and in Cells. PLoS One 2016;11:e0167439. [PMID: 27907175 DOI: 10.1371/journal.pone.0167439] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 70 |
Martín-burriel I, Roome NO, Dorchies O, Prenez A. Histopathological and Molecular Changes During Apoptosis Produced by 7H-Dibenzo[c,g]-Carbazole in Mouse Liver. Toxicol Pathol 2004;32:202-11. [DOI: 10.1080/01926230490274353] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 71 |
Mohd Yusof YA. Gingerol and Its Role in Chronic Diseases. In: Gupta SC, Prasad S, Aggarwal BB, editors. Drug Discovery from Mother Nature. Cham: Springer International Publishing; 2016. pp. 177-207. [DOI: 10.1007/978-3-319-41342-6_8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 72 |
Zhang Y, Lozano G. p53: Multiple Facets of a Rubik's Cube. Annu Rev Cancer Biol 2017;1:185-201. [PMID: 30775651 DOI: 10.1146/annurev-cancerbio-050216-121926] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 73 |
Laptenko O, Tong DR, Manfredi J, Prives C. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein. Trends Biochem Sci 2016;41:1022-34. [PMID: 27669647 DOI: 10.1016/j.tibs.2016.08.011] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 74 |
Goumenou A, Panayiotides I, Mahutte NG, Matalliotakis I, Fragouli Y, Arici A. Immunohistochemical Expression of p53, MDM2, and p21Wafi Oncoproteins in Endometriomas But Not Adenomyosis. Journal of the Society for Gynecologic Investigation 2016;12:263-6. [DOI: 10.1016/j.jsgi.2005.01.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 75 |
Xie Q, Wu MY, Zhang DX, Yang YM, Wang BS, Zhang J, Xu J, Zhong WD, Hu JN. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo. World J Gastroenterol 2016; 22(32): 7342-7352 [PMID: 27621580 DOI: 10.3748/wjg.v22.i32.7342] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
Costa MJ, Walls J, Dickerman A, Ames PF, Roth LM, Guinee D. Cell Cycle Control of Ovarian Granulosa Cells in Tumors and Cysts. Int J Surg Pathol 1996;4:61-9. [DOI: 10.1177/106689699600400201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 77 |
Robbins P. p53 and Breast Cancer. Int J Surg Pathol 1996;4:93-110. [DOI: 10.1177/106689699600400206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 78 |
. Poster Session. Toxicol Pathol 1993;21:623-46. [DOI: 10.1177/019262339302100613] [Reference Citation Analysis]
|
| 79 |
Perz E, Kuhn JG. Review : p53 in the pathogenesis, diagnosis, and treatment of cancer. J Oncol Pharm Pract 1998;4:75-102. [DOI: 10.1177/107815529800400201] [Reference Citation Analysis]
|
| 80 |
Gao W, Jin J, Yin J, Land S, Gaither-Davis A, Christie N, Luketich JD, Siegfried JM, Keohavong P. KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients. Mol Carcinog 2017;56:381-8. [PMID: 27182622 DOI: 10.1002/mc.22501] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 81 |
Fesler A, Zhang N, Ju J. The expanding regulatory universe of p53 in gastrointestinal cancer. F1000Res 2016;5:756. [PMID: 27508057 DOI: 10.12688/f1000research.8363.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 82 |
Shi H, Zhang A, He Y, Yang M, Gan W. Effects of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro. Mol Med Rep 2016;13:5102-8. [PMID: 27109859 DOI: 10.3892/mmr.2016.5156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 83 |
Vuichoud C, Klap J, Loughlin KR. The Emerging Role and Promise of Biomarkers in Penile Cancer. Urol Clin North Am 2016;43:135-43. [PMID: 26614036 DOI: 10.1016/j.ucl.2015.08.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 84 |
Erdemli HK, Akyol S, Armutcu F, Gulec MA, Canbal M, Akyol O. Melatonin and caffeic acid phenethyl ester in the regulation of mitochondrial function and apoptosis: The basis for future medical approaches. Life Sciences 2016;148:305-12. [DOI: 10.1016/j.lfs.2016.01.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 85 |
Pagliarone S, Frattone L, Pirocchi V, Della Salda L, Palmieri C. Altered expression of p53, but not Rb, is involved in canine prostatic carcinogenesis. Res Vet Sci 2016;105:195-9. [PMID: 27033932 DOI: 10.1016/j.rvsc.2016.02.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 86 |
Zhao H, Wang Q, Wang X, Zhu H, Zhang S, Wang W, Wang Z, Huang J. Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer. Pancreas 2016;45:204-10. [PMID: 26418905 DOI: 10.1097/MPA.0000000000000453] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 87 |
Jameson JL, Kopp P. Applications of Genetics in Endocrinology. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00004-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 88 |
Urbanska AM, Karagiannis ED, Au AS, Dai SY, Mozafari M, Prakash S. What's Next for Gastrointestinal Disorders: No Needles? J Control Release 2016;221:48-61. [PMID: 26646543 DOI: 10.1016/j.jconrel.2015.11.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 89 |
Ozaki T, Nakamura M, Shimozato O. Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2. Biomolecules. 2015;5:2854-2876. [PMID: 26512706 DOI: 10.3390/biom5042854] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 90 |
Sun R, Wang X, Zhu H, Mei H, Wang W, Zhang S, Huang J. Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues. Oncotarget 2014;5:12398-409. [PMID: 25362357 DOI: 10.18632/oncotarget.2643] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 91 |
Reeves R. High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells. DNA Repair (Amst). 2015;36:122-136. [PMID: 26411874 DOI: 10.1016/j.dnarep.2015.09.015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 92 |
Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2015. [DOI: 10.1002/9781118949139.ch8] [Reference Citation Analysis]
|
| 93 |
Prives C, Lowe SW. Cancer: Mutant p53 and chromatin regulation. Nature 2015;525:199-200. [PMID: 26331537 DOI: 10.1038/nature15212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 94 |
Sun Z. The General Information of the Tumor Suppressor Gene p53 and the Protein p53. JCPCR 2015;3. [DOI: 10.15406/jcpcr.2015.03.00068] [Reference Citation Analysis]
|
| 95 |
Zhang X, Huang Y, Shi X. Emerging roles of lysine methylation on non-histone proteins. Cell Mol Life Sci 2015;72:4257-72. [PMID: 26227335 DOI: 10.1007/s00018-015-2001-4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 96 |
Ismaiel A, Papenbrock J. Mycotoxins: Producing Fungi and Mechanisms of Phytotoxicity. Agriculture 2015;5:492-537. [DOI: 10.3390/agriculture5030492] [Cited by in Crossref: 134] [Cited by in F6Publishing: 136] [Article Influence: 16.8] [Reference Citation Analysis]
|
| 97 |
Bhardwaj S, Wani FA. Evaluating the Importance of Apoptotic Index, Mitotic Index and Turnover Index in Premalignant and Malignant Lesions of Cervix. OJPathology 2015;05:29-37. [DOI: 10.4236/ojpathology.2015.52005] [Reference Citation Analysis]
|
| 98 |
Neubauer A. Molekulare Grundlagen der malignen Transformation. SpringerReference Innere Medizin 2015. [DOI: 10.1007/978-3-642-54676-1_186-1] [Reference Citation Analysis]
|
| 99 |
Shi Y, Han Y, Xie F, Wang A, Feng X, Li N, Guo H, Chen D. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy. J Cell Mol Med 2015;19:535-43. [PMID: 25534115 DOI: 10.1111/jcmm.12435] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 100 |
Wang Q, Ni Q, Wang X, Zhu H, Wang Z, Huang J. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Med Oncol 2015;32:372. [PMID: 25428385 DOI: 10.1007/s12032-014-0372-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 101 |
Ozaki T, Sugimoto H, Nakamura M, Hiraoka K, Yoda H, Sang M, Fujiwara K, Nagase H. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity. FEBS J 2015;282:114-28. [PMID: 25331851 DOI: 10.1111/febs.13108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 102 |
Takami H, Yoshida A, Fukushima S, Arita H, Matsushita Y, Nakamura T, Ohno M, Miyakita Y, Shibui S, Narita Y, Ichimura K. Revisiting TP53 Mutations and Immunohistochemistry--A Comparative Study in 157 Diffuse Gliomas. Brain Pathol 2015;25:256-65. [PMID: 25040820 DOI: 10.1111/bpa.12173] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 103 |
Kim S, Kim DH, Lee SH, Kim MJ, Yoon JH, Chung HY, Na CS, Kim ND. Urushiol Induces Apoptosis via a p53-dependent Pathway in Human Gastric Cancer Cells. J Cancer Prev 2013;18:169-76. [PMID: 25337543 DOI: 10.15430/jcp.2013.18.2.169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 104 |
Cheung PF, Yip CW, Ng LW, Lo KW, Wong N, Choy KW, Chow C, Chan KF, Cheung TT, Poon RT, Fan ST, Cheung ST. Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo. Cancer Cell Int 2014;14:103. [PMID: 25349534 DOI: 10.1186/s12935-014-0103-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 105 |
García-tello A, Angulo J, Andrés G, Ramón de Fata F, Sánchez-chapado M, López J. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis. Actas Urológicas Españolas (English Edition) 2014;38:506-514. [DOI: 10.1016/j.acuroe.2014.07.005] [Reference Citation Analysis]
|
| 106 |
García-Tello A, Angulo JC, Andrés G, Ramón de Fata F, Sánchez-Chapado M, López JI. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis. Actas Urol Esp 2014;38:506-14. [PMID: 24702909 DOI: 10.1016/j.acuro.2014.02.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 107 |
Singh CR, Kathiresan K. Molecular understanding of lung cancers-A review. Asian Pac J Trop Biomed 2014;4:S35-41. [PMID: 25183110 DOI: 10.12980/APJTB.4.2014C597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 108 |
Okal A, Matissek KJ, Matissek SJ, Price R, Salama ME, Janát-Amsbury MM, Lim CS. Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model. Gene Ther 2014;21:903-12. [PMID: 25077773 DOI: 10.1038/gt.2014.70] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 109 |
Chang GS, Chen XA, Park B, Rhee HS, Li P, Han KH, Mishra T, Chan-Salis KY, Li Y, Hardison RC, Wang Y, Pugh BF. A comprehensive and high-resolution genome-wide response of p53 to stress. Cell Rep 2014;8:514-27. [PMID: 25043190 DOI: 10.1016/j.celrep.2014.06.030] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 110 |
Zhang Q, Ubago J, Li L, Guo H, Liu Y, Qiang W, Kim JJ, Kong B, Wei JJ. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma. Cancer. 2014;120:3165-3177. [PMID: 24986214 DOI: 10.1002/cncr.28900] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 111 |
Alqumber MA, Akhter N, Haque S, Panda AK, Mandal RK. Evaluating the association between p53 codon 72 Arg>pro polymorphism and risk of ovary cancer: a meta-analysis. PLoS One 2014;9:e94874. [PMID: 24747975 DOI: 10.1371/journal.pone.0094874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 112 |
Eisfeld AK, Schwind S, Patel R, Huang X, Santhanam R, Walker CJ, Markowitz J, Hoag KW, Jarvinen TM, Leffel B, Perrotti D, Carson WE 3rd, Marcucci G, Bloomfield CD, de la Chapelle A. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway. Sci Signal 2014;7:ra36. [PMID: 24736457 DOI: 10.1126/scisignal.2004762] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 113 |
Arican G, Arican E. Evaluation of the Apoptotic and Antiproliferative Activities of Paclitaxel in Ehrlich Ascites Tumor Cells. Biotechnology & Biotechnological Equipment 2014;20:69-75. [DOI: 10.1080/13102818.2006.10817382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 114 |
Beck GR, Zerler BR, Moran E. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus. In: Mccance DJ, editor. Human Tumor Viruses. Washington: ASM Press; 1998. pp. 51-86. [DOI: 10.1128/9781555818289.ch2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 115 |
Rao CV, Patlolla JM, Qian L, Zhang Y, Brewer M, Mohammed A, Desai D, Amin S, Lightfoot S, Kopelovich L. Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice. Neoplasia 2013;15:1018-27. [PMID: 24027427 DOI: 10.1593/neo.131256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 116 |
Wang F, He L, Huangyang P, Liang J, Si W, Yan R, Han X, Liu S, Gui B, Li W, Miao D, Jing C, Liu Z, Pei F, Sun L, Shang Y. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation. PLoS Biol. 2014;12:e1001819. [PMID: 24667498 DOI: 10.1371/journal.pbio.1001819] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 117 |
Eskander EF, Abd-Rabou AA, Yahya SM, El Sherbini A, Mohamed MS, Shaker OG. "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences". Indian J Clin Biochem 2014;29:3-7. [PMID: 24478542 DOI: 10.1007/s12291-013-0317-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 118 |
Ma HB, Huang S, Yin XR, Zhang Y, Di ZL. Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells. World J Gastroenterol 2014; 20(1): 193-203 [PMID: 24415872 DOI: 10.3748/wjg.v20.i1.193] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 119 |
Checler F, Alves da Costa C. p53 in neurodegenerative diseases and brain cancers. Pharmacol Ther 2014;142:99-113. [PMID: 24287312 DOI: 10.1016/j.pharmthera.2013.11.009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 120 |
Zhang W, Song J, Liang R, Zheng X, Chen J, Li G, Zhang B, Yan X, Wang R. Stearylated Antimicrobial Peptide Melittin and Its Retro Isomer for Efficient Gene Transfection. Bioconjugate Chem 2013;24:1805-12. [DOI: 10.1021/bc400053b] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 121 |
Simone CB 2nd, John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN. mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status. Transl Oncol 2013;6:573-85. [PMID: 24151538 DOI: 10.1593/tlo.13241] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 122 |
Singh V, Prajeeth CK, Gudi V, Bénardais K, Voss EV, Stangel M. 2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells. Clin Exp Immunol 2013;173:288-97. [PMID: 23607690 DOI: 10.1111/cei.12109] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 123 |
Huang Y, Yu P, Li W, Ren G, Roberts AI, Cao W, Zhang X, Su J, Chen X, Chen Q, Shou P, Xu C, Du L, Lin L, Xie N, Zhang L, Wang Y, Shi Y. p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation. Oncogene 2014;33:3830-8. [PMID: 23975435 DOI: 10.1038/onc.2013.355] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 124 |
Bektas M, Rubenstein DS. The role of intracellular protein O-glycosylation in cell adhesion and disease. J Biomed Res 2011;25:227-36. [PMID: 23554695 DOI: 10.1016/S1674-8301(11)60031-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 125 |
Ciccolini J, Fanciullino R, Milano G. Research Highlights: Highlights from the latest articles in pharmacogenomics. Pharmacogenomics 2013;14:1137-1139. [DOI: 10.2217/pgs.13.98] [Reference Citation Analysis]
|
| 126 |
Huang W, Deng B, Wang RW, Tan QY, Jiang YG. Expression of breast cancer anti-estrogen resistance 1 in relation to vascular endothelial growth factor, p53, and prognosis in esophageal squamous cell cancer. Dis Esophagus 2013;26:528-37. [PMID: 22816673 DOI: 10.1111/j.1442-2050.2012.01376.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 127 |
Shah H, Rawal Mahajan S. Photoaging: New insights into its stimulators, complications, biochemical changes and therapeutic interventions. Biomedicine & Aging Pathology 2013;3:161-9. [DOI: 10.1016/j.biomag.2013.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 128 |
Saleem S, Azhar A, Hameed A, Khan MA, Abbasi ZA, Qureshi NR, Ajmal M. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan. Oral Oncol 2013;49:818-23. [PMID: 23683469 DOI: 10.1016/j.oraloncology.2013.04.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 129 |
Ozaki T, Wu D, Sugimoto H, Nagase H, Nakagawara A. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Cell Death Dis 2013;4:e610. [PMID: 23618908 DOI: 10.1038/cddis.2013.127] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 130 |
Blaber EA, Dvorochkin N, Lee C, Alwood JS, Yousuf R, Pianetta P, Globus RK, Burns BP, Almeida EA. Microgravity induces pelvic bone loss through osteoclastic activity, osteocytic osteolysis, and osteoblastic cell cycle inhibition by CDKN1a/p21. PLoS One 2013;8:e61372. [PMID: 23637819 DOI: 10.1371/journal.pone.0061372] [Cited by in Crossref: 128] [Cited by in F6Publishing: 133] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 131 |
Carrera S, Cuadrado-Castano S, Samuel J, Jones GD, Villar E, Lee SW, Macip S. Stra6, a retinoic acid-responsive gene, participates in p53-induced apoptosis after DNA damage. Cell Death Differ. 2013;20:910-919. [PMID: 23449393 DOI: 10.1038/cdd.2013.14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 132 |
Takahashi M, Kakudo Y, Takahashi S, Sakamoto Y, Kato S, Ishioka C. Overexpression of DRAM enhances p53-dependent apoptosis. Cancer Med 2013;2:1-10. [PMID: 24133622 DOI: 10.1002/cam4.39] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 133 |
Sahora A, Khanna C. Cellular Growth/Neoplasia. Canine and Feline Gastroenterology 2013. [DOI: 10.1016/b978-1-4160-3661-6.00005-5] [Reference Citation Analysis]
|
| 134 |
Cheng T, Scadden DT. Cell Cycle Regulators in Stem Cells. Handbook of Stem Cells 2013. [DOI: 10.1016/b978-0-12-385942-6.00009-3] [Reference Citation Analysis]
|
| 135 |
Lefebvre KJ, Assadian S, El-assaad W, Teodoro JG. Regulation of Angiogenesis by Tumour Suppressor Pathways. Experimental and Clinical Metastasis 2013. [DOI: 10.1007/978-1-4614-3685-0_8] [Reference Citation Analysis]
|
| 136 |
Argyle DJ, Khanna C. Tumor Biology and Metastasis. Withrow and MacEwen's Small Animal Clinical Oncology 2013. [DOI: 10.1016/b978-1-4377-2362-5.00002-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 137 |
Yuan F, Li M, Li J. Identifying Disease Genes Based on Functional Annotation and Text Mining. Global Applications of Pervasive and Ubiquitous Computing 2013. [DOI: 10.4018/978-1-4666-2645-4.ch006] [Reference Citation Analysis]
|
| 138 |
Sailaja K, Rao VR, Yadav S, Reddy RR, Surekha D, Rao DN, Raghunadharao D, Vishnupriya S. Intronic SNPs of TP53 gene in chronic myeloid leukemia: Impact on drug response. J Nat Sci Biol Med 2012;3:182-5. [PMID: 23225982 DOI: 10.4103/0976-9668.101910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 139 |
Heng MC. Signaling pathways targeted by curcumin in acute and chronic injury: burns and photo-damaged skin. Int J Dermatol 2013;52:531-43. [PMID: 23231506 DOI: 10.1111/j.1365-4632.2012.05703.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 140 |
Ding C, Yu H, Yu H, Qin H. TP53 codon 72 polymorphism with hepatocellular carcinoma: a metaanalysis. J Int Med Res 2012;40:446-54. [PMID: 22613405 DOI: 10.1177/147323001204000206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 141 |
Wu D, Ozaki T, Yoshihara Y, Kubo N, Nakagawara A. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation. J Biol Chem 2013;288:1353-64. [PMID: 23148227 DOI: 10.1074/jbc.M112.402594] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 142 |
Cobanoglu HB, Constantinides M, Ural A. Nonmelanoma Skin Cancer of the Head and Neck. Facial Plastic Surgery Clinics of North America 2012;20:437-43. [DOI: 10.1016/j.fsc.2012.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 143 |
Shafi Sofi M, Sateesh MK, Bashir M, Harish G, Lakshmeesha TR, Vedashree S, Vedamurthy AB. Cytotoxic and pro-apoptotic effects of Abrus precatorius L. on human metastatic breast cancer cell line, MDA-MB-231. Cytotechnology 2013;65:407-17. [PMID: 23081723 DOI: 10.1007/s10616-012-9494-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 144 |
Friedrich MG, Schwaibold H, Wintzer O, Pichlmeier U, Huland H. p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder. Urol Oncol 1997;3:125-31. [PMID: 21227117 DOI: 10.1016/s1078-1439(98)00018-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 145 |
Mashima T, Seimiya H, Chen Z, Kataoka S, Tsuruo T. Apoptosis resistance in tumor cells. Cytotechnology. 1998;27:293-308. [PMID: 19002800 DOI: 10.1023/A:1008058031511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 146 |
Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors 2013;39:37-55. [PMID: 22996381 DOI: 10.1002/biof.1041] [Cited by in Crossref: 158] [Cited by in F6Publishing: 168] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 147 |
Bourthoumieu S, Magnaudeix A, Terro F, Leveque P, Collin A, Yardin C. Study of p53 expression and post-transcriptional modifications after GSM-900 radiofrequency exposure of human amniotic cells. Bioelectromagnetics 2013;34:52-60. [DOI: 10.1002/bem.21744] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 148 |
Scarpa M, Cardin R, Bortolami M, Kotsafti A, Scarpa MC, Pozza A, Maran G, Picciocchi M, Ruffolo C, D’Incà R. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NFκB signalling. Eur J Cancer. 2013;49:254-263. [PMID: 22704122 DOI: 10.1016/j.ejca.2012.05.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 149 |
Maritz GS, Mutemwa M. Tobacco smoking: patterns, health consequences for adults, and the long-term health of the offspring. Glob J Health Sci 2012;4:62-75. [PMID: 22980343 DOI: 10.5539/gjhs.v4n4p62] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 150 |
Prabha S, Sharma B, Labhasetwar V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Ther 2012;19:530-7. [PMID: 22595792 DOI: 10.1038/cgt.2012.26] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 151 |
Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, Nomura H, Tominaga E, Susumu N, Aoki D. Biomarkers in endometrial cancer: Possible clinical applications (Review). Oncol Lett 2012;3:1175-80. [PMID: 22783413 DOI: 10.3892/ol.2012.654] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 152 |
Marie SK, Shinjo SM. Metabolism and brain cancer. Clinics (Sao Paulo) 2011;66 Suppl 1:33-43. [PMID: 21779721 DOI: 10.1590/s1807-59322011001300005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 153 |
Shen H, Dong W, Gao D, Wang G, Ma G, Liu Q, Du J. MDM2 antagonist Nutlin-3a protects wild-type p53 cancer cells from paclitaxel. Chin Sci Bull 2012;57:1007-1012. [DOI: 10.1007/s11434-012-4984-7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 154 |
Scarpini S, Rouprêt M, Renard-penna R, Camparo P, Cussenot O, Compérat E. Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. Urologic Oncology: Seminars and Original Investigations 2012;30:182-7. [DOI: 10.1016/j.urolonc.2009.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 155 |
Koo T, Choi IK, Kim M, Lee JS, Oh E, Kim J, Yun CO. Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy. Hum Gene Ther 2012;23:609-22. [PMID: 22248367 DOI: 10.1089/hum.2011.114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 156 |
Ando M, Kado S, Suzuki T, Yamamoto R, Nagata Y, Hata C, Uchida K, Kaneko K. A Case Report of a Malignant Fibrous Histiocytoma in a T-cell Receptor β Chain and p53 Double-knockout Mouse. J Toxicol Pathol 2011;24:251-5. [PMID: 22319239 DOI: 10.1293/tox.24.251] [Reference Citation Analysis]
|
| 157 |
Sahu G, Jena RK. Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India. Hematol Rep 2011;3:e28. [PMID: 22593819 DOI: 10.4081/hr.2011.e28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 158 |
Nieva J, Song BD, Rogel JK, Kujawara D, Altobel L 3rd, Izharrudin A, Boldt GE, Grover RK, Wentworth AD, Wentworth P Jr. Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53. Chem Biol 2011;18:920-7. [PMID: 21802012 DOI: 10.1016/j.chembiol.2011.02.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 159 |
Abdelmoula-souissi S, Mabrouk I, Gargouri A, Mokdad-gargouri R. Expression of the human tumor suppressor p53 induces cell death in Pichia pastoris. FEMS Yeast Res 2012;12:2-8. [DOI: 10.1111/j.1567-1364.2011.00758.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 160 |
Jin M, Zhao W, Zhang Y, Kobayashi M, Duan H, Kong D. Antiproliferative effect of aaptamine on human chronic myeloid leukemia K562 cells. Int J Mol Sci 2011;12:7352-9. [PMID: 22174603 DOI: 10.3390/ijms12117352] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 161 |
Moon A, Won KY, Lee JY, Kang I, Lee S, Lee J. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix. Pathology 2011;43:453-8. [DOI: 10.1097/pat.0b013e3283484a3a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 162 |
Baseskioglu B, Akdogan B, Baydar DE, Ozen H. Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy? Indian J Urol 2010;26:206-12. [PMID: 20877598 DOI: 10.4103/0970-1591.65390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 163 |
Liao JC, Lam R, Brazda V, Duan S, Ravichandran M, Ma J, Xiao T, Tempel W, Zuo X, Wang YX. Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53. Structure. 2011;19:418-429. [PMID: 21397192 DOI: 10.1016/j.str.2010.12.015] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 164 |
Wu H, Leng RP. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation. Cell Cycle 2011;10:1912-5. [PMID: 21558803 DOI: 10.4161/cc.10.12.15882] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 165 |
Chae SW, Sohn JH, Kim DH, Choi YJ, Park YL, Kim K, Cho YH, Pyo JS, Kim JH. Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications. Yonsei Med J 2011;52:445-53. [PMID: 21488187 DOI: 10.3349/ymj.2011.52.3.445] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 166 |
Tabata K, Kurosaka S, Watanabe M, Edamura K, Satoh T, Yang G, Abdelfattah E, Wang J, Goltsov A, Floryk D, Thompson TC. Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model. Gene Ther 2011;18:969-78. [PMID: 21512508 DOI: 10.1038/gt.2011.51] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 167 |
Wang L, Zhang XY, Xu L, Liu WJ, Zhang J, Zhang JP. Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma. Oncol Lett 2011;2:707-12. [PMID: 22848253 DOI: 10.3892/ol.2011.292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 168 |
Luo KJ, Hu Y, Wen J, Fu JH. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. J Surg Oncol. 2011;104:236-243. [PMID: 21480261 DOI: 10.1002/jso.21921] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 169 |
Myllykangas S, Ji HP. Targeted deep resequencing of the human cancer genome using next-generation technologies. Biotechnol Genet Eng Rev 2010;27:135-58. [PMID: 21415896 DOI: 10.1080/02648725.2010.10648148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 170 |
Kim SH, Dass CR. p53-targeted cancer pharmacotherapy: move towards small molecule compounds. J Pharm Pharmacol 2011;63:603-10. [PMID: 21492161 DOI: 10.1111/j.2042-7158.2010.01248.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 171 |
Maritz GS, Harding R. Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: evidence for altered lung development. Int J Environ Res Public Health 2011;8:875-98. [PMID: 21556184 DOI: 10.3390/ijerph8030875] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 172 |
Ozaki T, Nakagawara A. Role of p53 in Cell Death and Human Cancers. Cancers (Basel) 2011;3:994-1013. [PMID: 24212651 DOI: 10.3390/cancers3010994] [Cited by in Crossref: 321] [Cited by in F6Publishing: 299] [Article Influence: 26.8] [Reference Citation Analysis]
|
| 173 |
Han JS, Cao D, Molberg KH, Sarode VR, Rao R, Sutton LM, Peng Y. Hormone receptor status rather than HER2 status is significantly associated with increased Ki-67 and p53 expression in triple-negative breast carcinomas, and high expression of Ki-67 but not p53 is significantly associated with axillary nodal metastasis in triple-negative and high-grade non-triple-negative breast carcinomas. Am J Clin Pathol 2011;135:230-7. [PMID: 21228363 DOI: 10.1309/AJCP9DV3EVZUATFV] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 174 |
de Zwaan SE, Haass NK. Genetics of basal cell carcinoma. Australas J Dermatol 2010;51:81-92; quiz 93-4. [PMID: 20546211 DOI: 10.1111/j.1440-0960.2009.00579.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 175 |
Yuan F, Li M, Li J. Identifying Disease Genes Based on Functional Annotation and Text Mining. International Journal of Advanced Pervasive and Ubiquitous Computing 2011;3:45-54. [DOI: 10.4018/japuc.2011010106] [Reference Citation Analysis]
|
| 176 |
Ozaki T, Nakagawara A. p53: the attractive tumor suppressor in the cancer research field. J Biomed Biotechnol 2011;2011:603925. [PMID: 21188172 DOI: 10.1155/2011/603925] [Cited by in Crossref: 61] [Cited by in F6Publishing: 74] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 177 |
Shih RS, Wong SH, Schoene NW, Zhang JJ, Lei KY. Enhanced Gadd45 expression and delayed G2/M progression are p53-dependent in zinc-supplemented human bronchial epithelial cells. Exp Biol Med (Maywood) 2010;235:932-40. [PMID: 20660093 DOI: 10.1258/ebm.2010.010076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 178 |
Wang YK, Hong YJ, Wei M, Wu Y, Huang ZQ, Chen RZ, Chen HZ. Curculigoside attenuates human umbilical vein endothelial cell injury induced by H2O2. Journal of Ethnopharmacology 2010;132:233-9. [DOI: 10.1016/j.jep.2010.08.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 179 |
Malaguarnera G, Giordano M, Paladina I, Berretta M, Cappellani A, Malaguarnera M. Serum markers of hepatocellular carcinoma. Dig Dis Sci 2010;55:2744-55. [PMID: 20339916 DOI: 10.1007/s10620-010-1184-7] [Cited by in Crossref: 126] [Cited by in F6Publishing: 132] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 180 |
Sohn HJ, Yoo KH, Jang GY, Lee JH, Choi BM, Lee JH, Bae IS, Yim HE, Son CS, Lee JW. Aldosterone modulates cell proliferation and apoptosis in the neonatal rat heart. J Korean Med Sci 2010;25:1296-304. [PMID: 20808672 DOI: 10.3346/jkms.2010.25.9.1296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 181 |
Saraç OS, Atalay V, Cetin-Atalay R. GOPred: GO molecular function prediction by combined classifiers. PLoS One 2010;5:e12382. [PMID: 20824206 DOI: 10.1371/journal.pone.0012382] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 182 |
Atha DH, Manne U, Grizzle WE, Wagner PD, Srivastava S, Reipa V. Standards for immunohistochemical imaging: a protein reference device for biomarker quantitation. J Histochem Cytochem 2010;58:1005-14. [PMID: 20805583 DOI: 10.1369/jhc.2010.956342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 183 |
Tsunoda T, Takashima Y, Fujimoto T, Koyanagi M, Yoshida Y, Doi K, Tanaka Y, Kuroki M, Sasazuki T, Shirasawa S. Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model. Neoplasia 2010;12:397-404. [PMID: 20454511 DOI: 10.1593/neo.10170] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 184 |
Leong AS, Lee AK. Biological indices in the assessment of breast cancer. Clin Mol Pathol. 1995;48:M221-M238. [PMID: 16696013 DOI: 10.1136/mp.48.5.m221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 185 |
Fegan CD, Davies FE. Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia. Clin Mol Pathol 1996;49:M185-91. [PMID: 16696072 DOI: 10.1136/mp.49.4.m185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 186 |
Kanavaros P, Kouvidou C, Dai Y, Tzardi M, Datseris G, Darivianaki K, Rontogianni D, Delides G. MDM-2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression. Clin Mol Pathol 1995;48:M322-5. [PMID: 16696032 DOI: 10.1136/mp.48.6.m322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 187 |
Lasota J. MOLECULAR GENETICS OF SOFT TISSUE TUMORS. Modern Soft Tissue Pathology 2010. [DOI: 10.1017/cbo9780511781049.006] [Reference Citation Analysis]
|
| 188 |
Gazzah AC, El Golli Bennour E, Bouaziz C, Abid S, Ladjimi M, Bacha H. Sequential events of apoptosis induced by zearalenone in cultured hepatocarcinoma cells. Mycotox Res 2010;26:187-97. [DOI: 10.1007/s12550-010-0053-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 189 |
Beckerman R, Prives C. Transcriptional regulation by p53. Cold Spring Harb Perspect Biol. 2010;2:a000935. [PMID: 20679336 DOI: 10.1101/cshperspect.a000935] [Cited by in Crossref: 394] [Cited by in F6Publishing: 429] [Article Influence: 30.3] [Reference Citation Analysis]
|
| 190 |
Heng MC. Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy: Curcumin targeted signaling pathways. International Journal of Dermatology 2010;49:608-22. [DOI: 10.1111/j.1365-4632.2010.04468.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 191 |
Han SH, Kim SK, Park K, Yi SY, Park H, Lyu H, Kim M, Chung BH. Detection of mutant p53 using field-effect transistor biosensor. Analytica Chimica Acta 2010;665:79-83. [DOI: 10.1016/j.aca.2010.03.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 192 |
Moro J, Tinucci-costa M, Silveira A, Gerardi D, Alessi A. Reactivity of p53 protein in canine transmissible venereal tumor. Arq Bras Med Vet Zootec 2010;62:318-23. [DOI: 10.1590/s0102-09352010000200011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 193 |
Neil JC, Wyke JA. Viral Oncogenicity. Topley & Wilson's Microbiology and Microbial Infections 2010. [DOI: 10.1002/9780470688618.taw0223] [Reference Citation Analysis]
|
| 194 |
Zhang W, Konopleva M, Burks JK, Dywer KC, Schober WD, Yang JY, McQueen TJ, Hung MC, Andreeff M. Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim. Cancer Res 2010;70:2424-34. [PMID: 20215498 DOI: 10.1158/0008-5472.CAN-09-0878] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 195 |
Kim D, Kim E, Na H, Sun Y, Surh Y. 15-Deoxy-Δ12,14-prostaglandin J2 stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. Oncogene 2010;29:2560-76. [DOI: 10.1038/onc.2010.8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 196 |
Kim H, Jang M, Lim S, Kim H, Kim S, Lee G, Kim J. Analysis of p53-Dependency of Differentially Expressed Genes by Capsaicin in Human Colorectal Cancer Cell. Journal of Life Science 2010;20:213-218. [DOI: 10.5352/jls.2010.20.2.213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 197 |
Hussein AM, Ahmed OM. Regioselective one-pot synthesis and anti-proliferative and apoptotic effects of some novel tetrazolo[1,5-a]pyrimidine derivatives. Bioorg Med Chem 2010;18:2639-44. [PMID: 20227281 DOI: 10.1016/j.bmc.2010.02.028] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 198 |
Liang F, Cho BP. Enthalpy-entropy contribution to carcinogen-induced DNA conformational heterogeneity. Biochemistry 2010;49:259-66. [PMID: 19961237 DOI: 10.1021/bi901629p] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 199 |
Vergis R, Corbishley CM, Thomas K, Horwich A, Huddart R, Khoo V, Eeles R, Sydes MR, Cooper CS, Dearnaley D, Parker C. Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation. Int J Radiat Oncol Biol Phys 2010;78:35-41. [PMID: 20092961 DOI: 10.1016/j.ijrobp.2009.07.1728] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 200 |
Liu X, Lu R, Wu S, Sun J. Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway. FEBS Lett 2010;584:911-6. [PMID: 20083111 DOI: 10.1016/j.febslet.2010.01.024] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 201 |
Kheirollahi M, Mehr-Azin M, Kamalian N, Mehdipour P. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors. Med Oncol 2011;28:7-14. [PMID: 20077038 DOI: 10.1007/s12032-009-9412-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 202 |
Jones J, Casey R, Karouia F. Ionizing Radiation as a Carcinogen*. Comprehensive Toxicology 2010. [DOI: 10.1016/b978-0-08-046884-6.01411-1] [Reference Citation Analysis]
|
| 203 |
Jameson JL, Kopp P. Applications of Genetics in Endocrinology. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00007-1] [Reference Citation Analysis]
|
| 204 |
Tang X, Yang X, Peng Y, Lin J. Protective Effects of Lycopene against H2O2-Induced Oxidative Injury and Apoptosis in Human Endothelial Cells. Cardiovasc Drugs Ther 2009;23:439-48. [DOI: 10.1007/s10557-009-6206-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 205 |
Gallagher EJ, Novosyadlyy R, Yakar S, Leroith D. The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms. In: Poretsky L, editor. Principles of Diabetes Mellitus. Boston: Springer US; 2010. pp. 579-99. [DOI: 10.1007/978-0-387-09841-8_36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 206 |
Ahn J, Poyurovsky MV, Baptiste N, Beckerman R, Cain C, Mattia M, McKinney K, Zhou J, Zupnick A, Gottifredi V, Prives C. Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 protein. Cell Cycle 2009;8:1603-15. [PMID: 19462533 DOI: 10.4161/cc.8.10.8548] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 207 |
Engelsen IB, Akslen LA, Salvesen HB. Biologic markers in endometrial cancer treatment. APMIS 2009;117:693-707. [DOI: 10.1111/j.1600-0463.2009.02467.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 208 |
Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer 2009;9:724-37. [PMID: 19776742 DOI: 10.1038/nrc2730] [Cited by in Crossref: 429] [Cited by in F6Publishing: 446] [Article Influence: 30.6] [Reference Citation Analysis]
|
| 209 |
Simões Magluta EP, da Cunha Vasconcelos F, Maia RC, Klumb CE. Insights into Apoptosis Mechanisms Induced by DNA-Damaging Agents in Burkitt's Lymphoma Cells. Cancer Investigation 2009;27:830-5. [DOI: 10.1080/07357900902849624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 210 |
Golubovskaya VM, Conway-Dorsey K, Edmiston SN, Tse CK, Lark AA, Livasy CA, Moore D, Millikan RC, Cance WG. FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer. 2009;125:1735-1738. [PMID: 19521985 DOI: 10.1002/ijc.24486] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 211 |
Maritz GS. Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring. Ther Adv Respir Dis 2009;3:193-210. [PMID: 19706643 DOI: 10.1177/1753465809343712] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 212 |
Kim D, Kim E, Na H, Surh Y. Effects of 15-Deoxy-Δ12,14-prostaglandin J2 on the Expression of p53 in MCF-7 Cells. Annals of the New York Academy of Sciences 2009;1171:202-9. [DOI: 10.1111/j.1749-6632.2009.04913.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 213 |
Ishimaru D, Ano Bom AP, Lima LM, Quesado PA, Oyama MF, de Moura Gallo CV, Cordeiro Y, Silva JL. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation. Biochemistry 2009;48:6126-35. [PMID: 19505151 DOI: 10.1021/bi9003028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 214 |
Sreeja L, Syamala V, Raveendran PB, Santhi S, Madhavan J, Ankathil R. p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population. Cancer Investigation 2009;26:41-6. [DOI: 10.1080/07357900701638459] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 215 |
Chang SC, Lin PC, Yang SH, Wang HS, Liang WY, Lin JK. Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis 2009;24:623-8. [PMID: 19198855 DOI: 10.1007/s00384-009-0663-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 216 |
Yedjou CG, Tchounwou PB. Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide. Mol Cell Biochem 2009;331:207-14. [PMID: 19444595 DOI: 10.1007/s11010-009-0160-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 217 |
Larghi EL, Bohn ML, Kaufman TS. Aaptamine and related products. Their isolation, chemical syntheses, and biological activity. Tetrahedron 2009;65:4257-82. [DOI: 10.1016/j.tet.2009.03.027] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 218 |
Wang W, Bergh A, Damber JE. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation. APMIS 2009;117:185-95. [PMID: 19245591 DOI: 10.1111/j.1600-0463.2008.00006.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 219 |
Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C, Ravid K. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J 2009;23:2741-8. [PMID: 19332642 DOI: 10.1096/fj.09-130963] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 220 |
Sarkar FH, Li Y, Wang Z, Kong D. Cellular signaling perturbation by natural products. Cell Signal 2009;21:1541-7. [PMID: 19298854 DOI: 10.1016/j.cellsig.2009.03.009] [Cited by in Crossref: 170] [Cited by in F6Publishing: 179] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 221 |
Colegrove KM, Gullanda FMD, Naydan DK, Lowenstine LJ. Tumor Morphology and Immunohistochemical Expression of Estrogen Receptor, Progesterone Receptor, p53, and Ki67 in Urogenital Carcinomas of California Sea Lions ( Zalophus californianus ). Vet Pathol 2009;46:642-55. [DOI: 10.1354/vp.08-vp-0214-c-fl] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 222 |
Inagaki Y, Tang W, Xu HL, Guo Q, Mafune K, Konishi T, Nakata M, Sugawara Y, Kokudo N. Localization of N-myc downstream-regulated gene 1 in gastric cancer tissue. Dig Liver Dis 2009;41:96-103. [PMID: 18602353 DOI: 10.1016/j.dld.2008.04.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 223 |
Benjamin CL, Melnikova VO, Ananthaswamy HN. p53 Protein and Pathogenesis of Melanoma and Nonmelanoma Skin Cancer. Sunlight, Vitamin D and Skin Cancer. [DOI: 10.1007/978-0-387-77574-6_21] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 224 |
Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008;14:8080-6. [PMID: 19088023 DOI: 10.1158/1078-0432.CCR-08-1422] [Cited by in Crossref: 116] [Cited by in F6Publishing: 127] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 225 |
Lakka S, Rao JS. Brain Tumor Angiogenesis. Handbook of Neurochemistry and Molecular Neurobiology 2009. [DOI: 10.1007/978-0-387-30375-8_1] [Reference Citation Analysis]
|
| 226 |
Yarosh DB, Peña A, Brown DA. DNA repair gene polymorphisms affect cytotoxicity in the National Cancer Institute Human Tumour Cell Line Screening Panel. Biomarkers 2008;10:188-202. [DOI: 10.1080/13547500500138732] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 227 |
Yongliang Li, Paul W. Brandt-rauf,. Circulating anti-p53 antibodies in lung cancer and relationship to histology and smoking. Biomarkers 2008;4:381-90. [DOI: 10.1080/135475099230769] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 228 |
Assadian S, Teodoro JG. Regulation of collagen-derived antiangiogenic factors by p53. Expert Opin Biol Ther 2008;8:941-50. [PMID: 18549324 DOI: 10.1517/14712598.8.7.941] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 229 |
Hill R, Leidal AM, Madureira PA, Gillis LD, Waisman DM, Chiu A, Lee PW. Chromium-mediated apoptosis: Involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. DNA Repair 2008;7:1484-99. [DOI: 10.1016/j.dnarep.2008.05.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 230 |
Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin North Am 2008;88:451-81, v. [PMID: 18514694 DOI: 10.1016/j.suc.2008.03.006] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 231 |
Schietinger A, Philip M, Schreiber H. Specificity in cancer immunotherapy. Semin Immunol 2008;20:276-85. [PMID: 18684640 DOI: 10.1016/j.smim.2008.07.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 232 |
Sánchez-Fayos Calabuig P, Martín Relloso MJ, Porres Cubero JC. [Genetic abnormalities of digestive tract adenocarcinomas and correlation with the histologic sequence of their development]. Med Clin (Barc) 2008;131:221-9. [PMID: 18674502 DOI: 10.1157/13124613] [Reference Citation Analysis]
|
| 233 |
Schrage YM, Lam S, Jochemsen AG, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovée JV. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro. J Cell Mol Med. 2009;13:2843-2852. [PMID: 18624751 DOI: 10.1111/j.1582-4934.2008.00406.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 234 |
Gönül II, Akyürek N, Dursun A, Küpeli B. Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. Pathol Res Pract 2008;204:707-17. [PMID: 18572327 DOI: 10.1016/j.prp.2008.03.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 235 |
Sánchez-Fayos Calabuig P, Martín Relloso MJ, Porres Cubero JC. [Genetic profile and molecular bases of pancreatic carcinogenesis]. Gastroenterol Hepatol 2007;30:592-6. [PMID: 18028855 DOI: 10.1157/13112587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 236 |
Yoshiya G, Takahata T, Hanada N, Suzuki K, Ishiguro A, Saito M, Sasaki M, Fukuda S. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol 2008;23:948-53. [PMID: 18205772 DOI: 10.1111/j.1440-1746.2008.05307.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 237 |
Maritz GS. Nicotine and lung development. Birth Defects Res C Embryo Today 2008;84:45-53. [PMID: 18383131 DOI: 10.1002/bdrc.20116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 238 |
Buck M. A novel domain of BRCA1 interacts with p53 in breast cancer cells. Cancer Lett 2008;268:137-45. [PMID: 18501503 DOI: 10.1016/j.canlet.2008.03.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 239 |
Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008;624:162-78. [PMID: 18348455 DOI: 10.1007/978-0-387-77574-6_13] [Cited by in Crossref: 131] [Cited by in F6Publishing: 108] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 240 |
Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN. p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 2008;84:55-62. [PMID: 18173701 DOI: 10.1111/j.1751-1097.2007.00213.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 241 |
Wang M, Li B, Wang C, Chen Y, Zuo Z. The concentration-dependent induction of cell death by trimethyltin chloride in rat liver epithelial IAR20 cells. Toxicol In Vitro 2008;22:1136-42. [PMID: 18411021 DOI: 10.1016/j.tiv.2008.02.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 242 |
Kulkarni A, Das KC. Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation. Am J Physiol Lung Cell Mol Physiol 2008;294:L998-L1006. [PMID: 18344416 DOI: 10.1152/ajplung.00004.2008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 243 |
Alimirah F, Panchanathan R, Chen J, Zhang X, Ho SM, Choubey D. Expression of androgen receptor is negatively regulated by p53. Neoplasia 2007;9:1152-9. [PMID: 18084622 DOI: 10.1593/neo.07769] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 244 |
Nakano J, Huang C, Liu D, Masuya D, Yokomise H, Ueno M, Haba R, Sumitomo S. The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers. Br J Cancer 2008;98:1109-17. [PMID: 18283319 DOI: 10.1038/sj.bjc.6604253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 245 |
Gau BH, Chu IM, Huang MC, Yang KT, Chiou SH, Fan YH, Chen MY, Lin JH, Chuang CK, Huang SY, Lee WC. Transcripts of enriched germ cells responding to heat shock as potential markers for porcine semen quality. Theriogenology 2008;69:758-66. [PMID: 18258292 DOI: 10.1016/j.theriogenology.2007.11.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 246 |
Atha DH. High-throughput DNA diagnostic measurements using capillary electrophoresis: p53, fragile X and telomerase. Expert Opinion on Medical Diagnostics 2008;2:91-100. [DOI: 10.1517/17530059.2.1.91] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 247 |
Wreesmann VB, Singh B. Clinical Impact of Molecular Analysis on Thyroid Cancer Management. Surgical Oncology Clinics of North America 2008;17:1-35. [DOI: 10.1016/j.soc.2007.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 248 |
Jeon CH, Lee HI, Shin IH, Park JW. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients. Int J Colorectal Dis 2008;23:29-35. [PMID: 17704924 DOI: 10.1007/s00384-007-0373-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 249 |
Welton ML, Shelton AA, Chang GJ, Varma MG. Colon, Rectum, and Anus. Surgery 2008. [DOI: 10.1007/978-0-387-68113-9_52] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 250 |
Ichwan SJA, Ikeda M. Defect in Ser46 Phosphorylation of p53 Protein : A Resistance Mechanism against p53 Gene Transfer in Oral Squamous Cell Carcinoma Cells. Journal of Oral Biosciences 2008;50:98-106. [DOI: 10.1016/s1349-0079(08)80023-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 251 |
Arief Ichwan SJ, Ikeda M. Defect in Ser46 Phosphorylation of p53 Protein: A Resistance Mechanism against p53 Gene Transfer in Oral Squamous Cell Carcinoma Cells. J Oral Biosci 2008;50:98-106. [DOI: 10.2330/joralbiosci.50.98] [Reference Citation Analysis]
|
| 252 |
Chao MM, Levine JE, Ruiz RE, Kohlmann WK, Bower MA, Petty EM, Mody RJ. Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation. Pediatr Blood Cancer 2007;49:1000-4. [PMID: 16333835 DOI: 10.1002/pbc.20700] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 253 |
Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg 2007;33:1099-101. [PMID: 17760601 DOI: 10.1111/j.1524-4725.2007.33224.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 254 |
Fuchs A, Marmur E. The Kinetics of Skin Cancer: Progression of Actinic Keratosis to Squamous Cell Carcinoma. Dermatologic Surgery 2007;33:1099-101. [DOI: 10.1097/00042728-200709000-00010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 255 |
Kim DH. Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer. Yonsei Med J 2007;48:694-700. [PMID: 17722244 DOI: 10.3349/ymj.2007.48.4.694] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 256 |
Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol. 2007;595:127-148. [PMID: 17569208 DOI: 10.1007/978-0-387-46401-5_4] [Cited by in Crossref: 132] [Cited by in F6Publishing: 126] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 257 |
Das P, Kotilingam D, Korchin B, Liu J, Yu D, Lazar AJ, Pollock RE, Lev D. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer 2007;109:2323-33. [PMID: 17429838 DOI: 10.1002/cncr.22680] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 258 |
Shishodia S, Chaturvedi MM, Aggarwal BB. Role of Curcumin in Cancer Therapy. Current Problems in Cancer 2007;31:243-305. [DOI: 10.1016/j.currproblcancer.2007.04.001] [Cited by in Crossref: 305] [Cited by in F6Publishing: 318] [Article Influence: 19.1] [Reference Citation Analysis]
|
| 259 |
Shaham J, Fireman E, Korenstein-ilan A, Lerman Y. Detection of p53 Protein in Induced Sputum After Occupational Exposure to Crystalline Silica. Journal of Occupational & Environmental Medicine 2007;49:730-5. [DOI: 10.1097/jom.0b013e31805d0be4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 260 |
Rass K. UV Damage and DNA Repair in Basal Cell and Squamous Cell Carcinomas. Medical Intelligence Unit. [DOI: 10.1007/0-387-35098-5_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 261 |
Melnikova VO, Ananthaswamy HN. p53 Protein and Nonmelanoma Skin Cancer. Medical Intelligence Unit. [DOI: 10.1007/0-387-35098-5_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 262 |
Yang D, Qi Y, Chen Q, Wang Z, Jin X, Gao J, Fu J, Xiao X, Zhou Z. The over-expression of p53 H179Y residue mutation causes the increase of cyclin A1 and Cdk4 expression in HELF cells. Mol Cell Biochem 2007;304:219-26. [PMID: 17530187 DOI: 10.1007/s11010-007-9503-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 263 |
Sforcin JM. Propolis and the immune system: a review. J Ethnopharmacol. 2007;113:1-14. [PMID: 17580109 DOI: 10.1016/j.jep.2007.05.012] [Cited by in Crossref: 378] [Cited by in F6Publishing: 392] [Article Influence: 23.6] [Reference Citation Analysis]
|
| 264 |
Bradbury AR, Olopade OI. Genetic susceptibility to breast cancer. Rev Endocr Metab Disord 2007;8:255-67. [DOI: 10.1007/s11154-007-9038-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 265 |
Iwakuma T, Lozano G. Crippling p53 activities via knock-in mutations in mouse models. Oncogene 2007;26:2177-84. [PMID: 17401426 DOI: 10.1038/sj.onc.1210278] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 266 |
Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol 2007;26:1-18. [PMID: 17263592 DOI: 10.1089/dna.2006.0505] [Cited by in Crossref: 206] [Cited by in F6Publishing: 218] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 267 |
Kuroda Y, Nakao H, Ikemura K, Katoh T. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol 2007;43:1043-8. [PMID: 17306604 DOI: 10.1016/j.oraloncology.2006.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 268 |
Sousa H, Santos AM, Catarino R, Pinto D, Vasconcelos A, Lopes C, Breda E, Medeiros R. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev. 2006;15:362-366. [PMID: 16835507 DOI: 10.1097/00008469-200608000-00010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 269 |
Buyru N, Altinisik J, Demokan S, Dalay N. p53 genotypes and haplotypes associated with risk of breast cancer. Cancer Detection and Prevention 2007;31:207-13. [DOI: 10.1016/j.cdp.2007.04.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 270 |
Gauthaman K, Richards M, Wong J, Bongso A. Comparative evaluation of the effects of statins on human stem and cancer cells in vitro. Reproductive BioMedicine Online 2007;15:566-81. [DOI: 10.1016/s1472-6483(10)60390-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 271 |
Markovic O, Marisavljevic D, Cemerikic V, Perunicic M, Colovic M. The expression of p53 protein in patients with multiple myeloma. Srp Arh Celok Lek 2007;135:43-7. [DOI: 10.2298/sarh0702043m] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 272 |
Wang S, El-deiry WS. P53, Cell Cycle Arrest and Apoptosis. 25 Years of p53 Research 2007. [DOI: 10.1007/978-1-4020-2922-6_6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 273 |
Mckinney K, Prives C. Regulation of p53 DNA Binding. 25 Years of p53 Research 2007. [DOI: 10.1007/978-1-4020-2922-6_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 274 |
Sehgal PB, Wang L, Rayanade R, Pan H, Margulies L. Interleukin-6-Type Cytokinesa. Annals of the New York Academy of Sciences 1995;762:1-14. [DOI: 10.1111/j.1749-6632.1995.tb32309.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 275 |
Benjamin CL, Ananthaswamy HN. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2007;224:241-8. [PMID: 17270229 DOI: 10.1016/j.taap.2006.12.006] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 276 |
Haupt S, Haupt Y. Importance of p53 for cancer onset and therapy. Anticancer Drugs. 2006;17:725-732. [PMID: 16926623 DOI: 10.1097/01.cad.0000217422.52208.fa] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 277 |
Mattia M, Gottifredi V, McKinney K, Prives C. p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled. Mol Cell Biol 2007;27:1309-20. [PMID: 17158927 DOI: 10.1128/MCB.01520-06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 278 |
Jane C, Nerurkar AV, Shirsat NV, Deshpande RB, Amrapurkar AD, Karjodkar FR. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 2006;35:595-601. [DOI: 10.1111/j.1600-0714.2006.00473.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 279 |
Ping-yuan L, Hung-jen L, Meng-jiun L, Feng-ling Y, Hsue-yin H, Jeng-woei L, Wen-ling S. Avian Reovirus activates a novel proapoptotic signal by linking Src to p53. Apoptosis 2006;11:2179-93. [DOI: 10.1007/s10495-006-0291-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 280 |
Kim WH, Lee JW, Gao B, Jung MH. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal 2005;17:1516-32. [PMID: 15908180 DOI: 10.1016/j.cellsig.2005.03.020] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 281 |
Hestekin CN, Jakupciak JP, Chiesl TN, Kan CW, O'connell CD, Barron AE. An optimized microchip electrophoresis system for mutation detection by tandem SSCP and heteroduplex analysis for p53 gene exons 5–9. Electrophoresis 2006;27:3823-35. [DOI: 10.1002/elps.200600358] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 282 |
Benjamin C, Ananthaswamy H. Etiology of Nonmelanocytic Skin Cancer. Skin Cancer Prevention 2006. [DOI: 10.3109/9781420021097-3] [Reference Citation Analysis]
|
| 283 |
Bai J, Cederbaum AI. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels. J Pharmacol Exp Ther 2006;319:1435-43. [PMID: 16971506 DOI: 10.1124/jpet.106.110007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 284 |
Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Höfler H, Sarbia M. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol 2006;59:631-4. [PMID: 16731604 DOI: 10.1136/jcp.2005.034298] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 285 |
Nakamura Y, Suzuki S, Suzuki T, Ono K, Miura I, Satoh F, Moriya T, Saito H, Yamada S, Ito S, Sasano H. MDM2: a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling. Am J Pathol 2006;169:362-71. [PMID: 16877339 DOI: 10.2353/ajpath.2006.051351] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 286 |
Xue-jun X, Yao G, Gui-ying Z, Guo-zheng G. The effect of wild-type p53 on the response of K562 to EMP. The 2006 4th Asia-Pacific Conference on Environmental Electromagnetics 2006. [DOI: 10.1109/ceem.2006.257970] [Reference Citation Analysis]
|
| 287 |
Ternovoi VV, Curiel DT, Smith BF, Siegal GP. Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma. Lab Invest 2006;86:748-66. [PMID: 16751779 DOI: 10.1038/labinvest.3700444] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 288 |
Hershey AE, Dubielzig RR, Padilla ML, Helfand SC. Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis. Vet Pathol 2005;42:805-11. [PMID: 16301577 DOI: 10.1354/vp.42-6-805] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 289 |
Qin G, Kishore R, Dolan CM, Silver M, Wecker A, Luedemann CN, Thorne T, Hanley A, Curry C, Heyd L, Dinesh D, Kearney M, Martelli F, Murayama T, Goukassian DA, Zhu Y, Losordo DW. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A 2006;103:11015-20. [PMID: 16835303 DOI: 10.1073/pnas.0509533103] [Cited by in Crossref: 85] [Cited by in F6Publishing: 89] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 290 |
Leonard K, Marugan JJ, Raboisson P, Calvo R, Gushue JM, Koblish HK, Lattanze J, Zhao S, Cummings MD, Player MR, Maroney AC, Lu T. Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity. Bioorganic & Medicinal Chemistry Letters 2006;16:3463-8. [DOI: 10.1016/j.bmcl.2006.04.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 291 |
Lee YS, Bae SM, Kwak SY, Park DC, Kim YW, Hur SY, Park EK, Han BD, Lee YJ, Kim CK, Kim DK, Ahn WS. Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells. Cancer Res Treat 2006;38:168-77. [PMID: 19771278 DOI: 10.4143/crt.2006.38.3.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 292 |
Galmarini CM, Bouchet BP, Audoynaud C, Lamblot C, Falette N, Bertholon J, Wang Q, Beghin A, Dumontet C, Puisieux A. A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells. Int J Cancer 2006;119:60-6. [PMID: 16432835 DOI: 10.1002/ijc.21770] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 293 |
Marugan JJ, Leonard K, Raboisson P, Gushue JM, Calvo R, Koblish HK, Lattanze J, Zhao S, Cummings MD, Player MR, Schubert C, Maroney AC, Lu T. Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists. Bioorganic & Medicinal Chemistry Letters 2006;16:3115-20. [DOI: 10.1016/j.bmcl.2006.03.067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 294 |
Ren C, Ren CH, Li L, Goltsov AA, Thompson TC. Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene cluster. Genomics 2006;88:163-72. [PMID: 16714093 DOI: 10.1016/j.ygeno.2006.03.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 295 |
Ishikawa K, Koyama-saegusa K, Otsuka Y, Ishikawa A, Kawai S, Yasuda K, Suga T, Michikawa Y, Suzuki M, Iwakawa M, Imai T. Gene expression profile changes correlating with radioresistance in human cell lines. International Journal of Radiation Oncology*Biology*Physics 2006;65:234-45. [DOI: 10.1016/j.ijrobp.2005.12.048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 296 |
Lee YJ, Chung DY, Lee SJ, Ja Jhon G, Lee YS. Enhanced radiosensitization of p53 mutant cells by oleamide. Int J Radiat Oncol Biol Phys 2006;64:1466-74. [PMID: 16580498 DOI: 10.1016/j.ijrobp.2005.11.033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 297 |
Murata H, Sakaguchi M, Futami J, Kitazoe M, Maeda T, Doura H, Kosaka M, Tada H, Seno M, Huh N, Yamada H. Denatured and Reversibly Cationized p53 Readily Enters Cells and Simultaneously Folds to the Functional Protein in the Cells. Biochemistry 2006;45:6124-32. [DOI: 10.1021/bi052642a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 298 |
Hayes VM, Dirven CM, Dam A, Verlind E, Molenaar WM, Mooij JJ, Hofstra RM, Buys CH. High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors. Brain Pathol 1999;9:463-7. [PMID: 10416986 DOI: 10.1111/j.1750-3639.1999.tb00535.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 299 |
Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. J Neurosci 2005;25:2295-303. [PMID: 15745955 DOI: 10.1523/JNEUROSCI.5107-04.2005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 300 |
Zhang P, Zhang J, Sheng H, Russo JJ, Osborne B, Buetow K. Gene functional similarity search tool (GFSST). BMC Bioinformatics 2006;7:135. [PMID: 16536867 DOI: 10.1186/1471-2105-7-135] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 301 |
Zhou J, Lim CU, Li JJ, Cai L, Zhang Y. The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage. Cancer Lett 2006;243:9-15. [PMID: 16530324 DOI: 10.1016/j.canlet.2006.01.026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 302 |
Raj D, Brash DE, Grossman D. Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 2006;126:243-57. [PMID: 16418733 DOI: 10.1038/sj.jid.5700008] [Cited by in Crossref: 153] [Cited by in F6Publishing: 162] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 303 |
Jin H, Bae S, Kim Y, Lee J, Namkoong S, Han B, Lee Y, Kim C, Chun H, Ahn W. Distinctive cell cycle regulatory protein profiles by adenovirus delivery of p53 in human papillomavirus-associated cancer cells. Int J Gynecol Cancer 2006;16:698-707. [DOI: 10.1111/j.1525-1438.2006.00393.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 304 |
Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397-1421. [PMID: 16563357 DOI: 10.1016/j.bcp.2006.02.009] [Cited by in Crossref: 1174] [Cited by in F6Publishing: 1231] [Article Influence: 69.1] [Reference Citation Analysis]
|
| 305 |
Aoki S, Kong D, Suna H, Sowa Y, Sakai T, Setiawan A, Kobayashi M. Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner. Biochem Biophys Res Commun 2006;342:101-6. [PMID: 16480688 DOI: 10.1016/j.bbrc.2006.01.119] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 306 |
Cheung HH, Arora V, Korneluk RG. Abnormalities of cell structures in tumors: apoptosis in tumors. EXS 2006;:201-21. [PMID: 16383020 DOI: 10.1007/3-7643-7378-4_9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 307 |
Wang S, El-Deiry WS. The p53 pathway: targets for the development of novel cancer therapeutics. Cancer Treat Res 2004;119:175-87. [PMID: 15164878 DOI: 10.1007/1-4020-7847-1_9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 308 |
Twu C, Jiang R, Shu C, Lin J. Association of p53 Codon 72 Polymorphism with Risk of Hypopharyngeal Squamous Cell Carcinoma in Taiwan. Journal of the Formosan Medical Association 2006;105:99-104. [DOI: 10.1016/s0929-6646(09)60330-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 309 |
Kishi S. Zebrafish as Aging Models. Handbook of Models for Human Aging. Elsevier; 2006. pp. 317-38. [DOI: 10.1016/b978-012369391-4/50029-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 310 |
Figge JJ, Kartel NA, Yarmolinsky D, Ermak G. Molecular Pathogenesis of Thyroid Cancer. Thyroid Cancer 2006. [DOI: 10.1007/978-1-59259-995-0_3] [Reference Citation Analysis]
|
| 311 |
Oh JH, Kim HS, Kim HH, Kim WH, Lee SH. Aberrant methylation of p14ARF gene correlates with poor survival in osteosarcoma. Clin Orthop Relat Res 2006;442:216-22. [PMID: 16394764 DOI: 10.1097/01.blo.0000188063.56091.69] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 312 |
Liu G, Chen X. Regulation of the p53 transcriptional activity. J Cell Biochem 2006;97:448-58. [DOI: 10.1002/jcb.20700] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 313 |
Xu GW, Mymryk JS, Cairncross JG. Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatin. J Neurooncol 2005;74:141-9. [PMID: 16193384 DOI: 10.1007/s11060-004-6601-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 314 |
Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Tomoyose T, Takano H, Funaki K, Fukuyama H, Takahashi T, Sakoda S. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. J Oral Pathol Med 2005;34:602-7. [PMID: 16202080 DOI: 10.1111/j.1600-0714.2005.00358.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 315 |
Ross DA, Wilson GD. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma: EXPRESSION OF p53 IN CUTANEOUS MELANOMA. Br J Surg 1997;84:803-7. [DOI: 10.1046/j.1365-2168.1997.02657.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 316 |
Ranga RS, Sowmyalakshmi S, Burikhanov R, Akbarsha MA, Chendil D. A herbal medicine for the treatment of lung cancer. Mol Cell Biochem 2005;280:125-33. [DOI: 10.1007/s11010-005-8518-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 317 |
Liu HJ, Lin PY, Lee JW, Hsu HY, Shih WL. Retardation of cell growth by avian reovirus p17 through the activation of p53 pathway. Biochem Biophys Res Commun 2005;336:709-15. [PMID: 16143310 DOI: 10.1016/j.bbrc.2005.08.149] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 318 |
Shuh M, Beilke M. The human T-cell leukemia virus type 1 (HTLV-1): New insights into the clinical aspects and molecular pathogenesis of adult t-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM). Microsc Res Tech 2005;68:176-96. [DOI: 10.1002/jemt.20231] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 319 |
Weissman B. Tumor Suppressor Genes. Molecular Carcinogenesis and the Molecular Biology of Human Cancer 2005. [DOI: 10.1201/9780203503430.ch6] [Reference Citation Analysis]
|
| 320 |
Yang SC, Chiu CL, Huang CC, Chen JR. Apoptosis induced by nucleosides in the human hepatoma HepG2. World J Gastroenterol 2005; 11(40): 6381-6384 [PMID: 16419169 DOI: 10.3748/wjg.v11.i40.6381] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 321 |
Kopp R, Diebold J, Dreier I, Cramer C, Glas J, Baretton G, Jauch KW. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections? Surg Endosc 2005;19:1507-12. [DOI: 10.1007/s00464-005-0043-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 322 |
Osada M, Park HL, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol. 2005;25:6077-6089. [PMID: 15988020 DOI: 10.1128/MCB.25.14.6077-6089.2005] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 323 |
Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, McManus BM, Yang D. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Mol Cell Biol 2005;25:6247-58. [PMID: 15988033 DOI: 10.1128/MCB.25.14.6247-6258.2005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 324 |
Schlom J, Tsang KY, Kantor JA, Abrams SI, Zaremba S, Greiner J, Hodge JW. Cancer vaccine development. Expert Opin Investig Drugs 1998;7:1439-52. [PMID: 15992042 DOI: 10.1517/13543784.7.9.1439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 325 |
Yang L. Disfunction of the Apoptotic Pathway in Cancer Cells. Application of Apoptosis to Cancer Treatment. [DOI: 10.1007/1-4020-3302-8_1] [Reference Citation Analysis]
|
| 326 |
Reeves R, Adair JE. Role of high mobility group (HMG) chromatin proteins in DNA repair. DNA Repair 2005;4:926-38. [DOI: 10.1016/j.dnarep.2005.04.010] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 327 |
Osada M, Nagakawa Y, Park HL, Yamashita K, Wu G, Sook Kim M, Fomenkov A, Trink B, Sidransky D. p63-Specific Activation of the BPAG-1e Promoter. Journal of Investigative Dermatology 2005;125:52-60. [DOI: 10.1111/j.0022-202x.2005.23801.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 328 |
Nistér M, Tang M, Zhang XQ, Yin C, Beeche M, Hu X, Enblad G, van Dyke T, Wahl GM. p53 must be competent for transcriptional regulation to suppress tumor formation. Oncogene 2005;24:3563-73. [PMID: 15750633 DOI: 10.1038/sj.onc.1208354] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 329 |
Wang XL, Wang J. Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg 2005;29:344-53. [PMID: 15696395 DOI: 10.1007/s00268-004-7819-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 330 |
Guo J, Chu M, Abbeyquaye T, Chen CY. Persistent nicotine treatment potentiates amplification of the dihydrofolate reductase gene in rat lung epithelial cells as a consequence of Ras activation. J Biol Chem 2005;280:30422-31. [PMID: 15983034 DOI: 10.1074/jbc.M504688200] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 331 |
Wright JW, Stouffer RL, Rodland KD. High-dose estrogen and clinical selective estrogen receptor modulators induce growth arrest, p21, and p53 in primate ovarian surface epithelial cells. J Clin Endocrinol Metab 2005;90:3688-95. [PMID: 15755852 DOI: 10.1210/jc.2004-2456] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 332 |
Nakano M, Taura Y, Inoue M. Protein expression of Mdm2 and p53 in hyperplastic and neoplastic lesions of the canine circumanal gland. J Comp Pathol 2005;132:27-32. [PMID: 15629477 DOI: 10.1016/j.jcpa.2004.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 333 |
Yu EY, Hahn WC. Genetic alterations in prostate cancer. Clin Prostate Cancer 2005;3:220-9. [PMID: 15882478 DOI: 10.3816/cgc.2005.n.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 334 |
Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A 2005;102:5535-40. [PMID: 15809436 DOI: 10.1073/pnas.0501828102] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 335 |
Das A, Tan WL, Smith DR. p53 point mutation is rare in meningiomas from Singaporean patients. Asian J Surg 2005;28:7-10. [PMID: 15691789 DOI: 10.1016/S1015-9584(09)60249-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 336 |
Okumura H, Natsugoe S, Matsumoto M, Mataki Y, Takatori H, Ishigami S, Takao S, Aikou T. The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma. Br J Cancer 2005;92:284-9. [PMID: 15655547 DOI: 10.1038/sj.bjc.6602322] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 337 |
Li C, Lin M, Liu J. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis. Oncogene 2004;23:9336-47. [PMID: 15531928 DOI: 10.1038/sj.onc.1208114] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 338 |
Forones NM, Carvalho APS, Giannotti-filho O, Lourenço LG, Oshima CTF. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq Gastroenterol 2005;42:30-4. [DOI: 10.1590/s0004-28032005000100008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 339 |
Sugai T, Habano W, Uesugi N, Jao YF, Nakamura S, Abe K, Takagane A, Terashima M. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers--a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol. 2004;17:1223-1234. [PMID: 15827559 DOI: 10.1038/sj.bjc.6602533] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 340 |
Sun Y, Zeng XR, Wenger L, Firestein GS, Cheung HS. P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex. J Cell Biochem. 2004;92:258-269. [PMID: 15108353 DOI: 10.1002/jcb.20044] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 341 |
Spieth C, Streichert F, Speer N, Sinzger C, Eberhard K, Zell A. Predicting Single Genes Related to Immune-Relevant Processes. 2005 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology 2005. [DOI: 10.1109/cibcb.2005.1594955] [Reference Citation Analysis]
|
| 342 |
Hossain MMI, Uzzaman MA, Nishioka M, Sakamoto K, Esguerra RL, Yamaguchi A, Takagi M. Expression of p53, mdm2 and p21 Proteins in Betal Quid and Tobacco Associated Oral Squamous Cell Carcinoma in Bangladeshi Population. Oral Med Pathol 2005;10:23-31. [DOI: 10.3353/omp.10.23] [Reference Citation Analysis]
|
| 343 |
Paleček E. Electroactivity of Proteins: Possibilities in Biomedicine and Proteomics. Electrochemistry of Nucleic Acids and Proteins – Towards Electrochemical Sensors for Genomics and Proteomics. Elsevier; 2005. pp. 689-750. [DOI: 10.1016/s1871-0069(05)01019-0] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 344 |
Janigro D, Dini G, Hallene K, Kight K. The Role of Multiple Drug Resistance in Neuroglial Survival. The Role of Glia in Neurotoxicity, Second Edition 2004. [DOI: 10.1201/9781420039740.ch15] [Reference Citation Analysis]
|
| 345 |
Sheu LF, Chen A, Lee HS, Hsu HY, Yu DS. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol Int. 2004;54:475-485. [PMID: 15189500 DOI: 10.1111/j.1440-1827.2004.01654.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 346 |
Sunar-Reeder B, Atha DH, Aydemir S, Reeder DJ, Tully L, Khan AR, O'Connell CD. Use of TP53 reference materials to validate mutations in clinical tissue specimens by single-strand conformational polymorphism analysis. Mol Diagn 2004;8:123-30. [PMID: 15527327 DOI: 10.1007/BF03260055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 347 |
Macwhinnie N, Monaghan H. The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma. Int J Gynecol Cancer 2004;14:938-46. [PMID: 15361207 DOI: 10.1111/j.1048-891X.2004.14533.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 348 |
Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol 2004;22:189-96. [PMID: 15262304 DOI: 10.1016/j.clindermatol.2003.12.006] [Cited by in Crossref: 94] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 349 |
Bortoluzzi MC, Yurgel LS, Dekker NP, Jordan RC, Regezi JA. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2004;98:698-704. [DOI: 10.1016/j.tripleo.2004.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 350 |
Gruber A, Schmidt P, Url A. Immunohistochemical Studies Concerning the Neuronal Cell Cycle of the Cat using PCNA, Ki-67 and p53 Markers. J Vet Med Series A 2004;51:416-9. [DOI: 10.1111/j.1439-0442.2004.00669.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 351 |
Sarkar FH, Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 2004;555:53-64. [PMID: 15476851 DOI: 10.1016/j.mrfmmm.2004.04.015] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 352 |
Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Lung Cancer. 2004;45:181-188. [PMID: 15246189 DOI: 10.1016/j.lungcan.2004.01.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 353 |
Wang L, Bowman L, Lu Y, Rojanasakul Y, Mercer RR, Castranova V, Ding M. Essential role of p53 in silica-induced apoptosis. Am J Physiol Lung Cell Mol Physiol 2005;288:L488-96. [PMID: 15557088 DOI: 10.1152/ajplung.00123.2003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 354 |
Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs). Mutat Res 2004;554:175-83. [PMID: 15450416 DOI: 10.1016/j.mrfmmm.2004.04.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 355 |
Anzola M, Saiz A, Cuevas N, Lopez-Martinez M, Martinez de Pancorbo MA, Burgos JJ. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma. J Viral Hepat 2004;11:502-10. [PMID: 15500550 DOI: 10.1111/j.1365-2893.2004.00541.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 356 |
Cheng T. Cell cycle inhibitors in normal and tumor stem cells. Oncogene 2004;23:7256-66. [PMID: 15378085 DOI: 10.1038/sj.onc.1207945] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 357 |
Karayi MK, Markham AF. Molecular biology of prostate cancer. Prostate Cancer Prostatic Dis. 2004;7:6-20. [PMID: 14999233 DOI: 10.1038/sj.pcan.4500697] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 358 |
Teitell MA, Pandolfi PP. Lymphoid Malignancies. In: Holland EC, editor. Mouse Models of Human Cancer. Hoboken: John Wiley & Sons, Inc.; 2004. [DOI: 10.1002/0471675067.mmc014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 359 |
Mori N, Delsite R, Natarajan K, Kulawiec M, Bhujwalla ZM, Singh KK. Loss of P53 Function in Colon Cancer Cells Results in Increased Phosphocholine and Total Choline. Mol Imaging 2004;3:153535002004041. [DOI: 10.1162/15353500200404121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 360 |
Hodgson SV, Morrison PJ, Irving M. Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice. Am J Med Genet C Semin Med Genet 2004;129C:56-64. [PMID: 15264273 DOI: 10.1002/ajmg.c.30019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 361 |
Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene. 2004;23:6500-6523. [PMID: 15322521 DOI: 10.1038/sj.onc.1207811] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 362 |
Elgavish A, Wood PA, Pinkert CA, Eltoum IE, Cartee T, Wilbanks J, Mentor-Marcel R, Tian L, Scroggins SE. Transgenic mouse with human mutant p53 expression in the prostate epithelium. Prostate 2004;61:26-34. [PMID: 15287091 DOI: 10.1002/pros.20071] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 363 |
Keohavong P, Gao WM, Mady HH, Kanbour-Shakir A, Melhem MF. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Cancer Lett 2004;212:121-30. [PMID: 15246568 DOI: 10.1016/j.canlet.2004.03.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 364 |
Miyake H, Hara I, Kamidono S, Eto H. MULTIFOCAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND UPPER URINARY TRACT: MOLECULAR SCREENING OF CLONAL ORIGIN BY CHARACTERIZING CD44 ALTERNATIVE SPLICING PATTERNS. Journal of Urology 2004;172:1127-9. [DOI: 10.1097/01.ju.0000129541.23460.48] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 365 |
Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S, Ochiai A, Ueda M, Kimata K. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis 2004;21:57-63. [PMID: 15065603 DOI: 10.1023/b:clin.0000017203.71293.e0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 366 |
Ahn WS, Bae SM, Lee JM, Namkoong SE, Yoo JY, Seo YS, Nam SL, Cho YL, Nam KH, Kim CK, Kim YW. Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo. Int J Gynecol Cancer 2004;14:322-32. [PMID: 15086733 DOI: 10.1111/j.1048-891x.2004.014217.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 367 |
Markovic O, Marisavljevic D, Cemerikic V, Suvajdzic N, Milic N, Colovic M. Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance. Med Oncol 2004;21:73-80. [PMID: 15034217 DOI: 10.1385/MO:21:1:73] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 368 |
Re RN, Cook JL, Giardina JF. The inhibition of tumor growth by triplex-forming oligonucleotides. Cancer Lett 2004;209:51-3. [PMID: 15145520 DOI: 10.1016/j.canlet.2004.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 369 |
Yu ZW, Zhao P, Liu M, Dong XS, Tao J, Yao XQ, Yin XH, Li Y, Fu SB. Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resiatant human colon carcinoma LoVo/5-FU cells. World J Gastroenterol 2004; 10(13): 1979-1983 [PMID: 15222051 DOI: 10.3748/wjg.v10.i13.1979] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 370 |
Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, Husain SA, Das BC. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 2003;252:117-24. [PMID: 14577584 DOI: 10.1023/a:1025546610920] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 371 |
Jüngst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 2004;39:1663-72. [PMID: 15185308 DOI: 10.1002/hep.20241] [Cited by in Crossref: 98] [Cited by in F6Publishing: 108] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 372 |
Lehrbach DM, Nita ME, Cecconello I. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq Gastroenterol. 2003;40:256-261. [PMID: 15264049 DOI: 10.1590/s0004-28032003000400011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 373 |
Allendorf J, Ippagunta N, Emond J. Management of liver metastases: new horizons for biologically based therapy. J Surg Res 2004;117:144-53. [PMID: 15013725 DOI: 10.1016/j.jss.2003.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 374 |
Chan WM, Siu WY, Lau A, Poon RY. How many mutant p53 molecules are needed to inactivate a tetramer? Mol Cell Biol 2004;24:3536-51. [PMID: 15060172 DOI: 10.1128/MCB.24.8.3536-3551.2004] [Cited by in Crossref: 117] [Cited by in F6Publishing: 127] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 375 |
Fujiuchi N, Aglipay JA, Ohtsuka T, Maehara N, Sahin F, Su GH, Lee SW, Ouchi T. Requirement of IFI16 for the Maximal Activation of p53 Induced by Ionizing Radiation. Journal of Biological Chemistry 2004;279:20339-44. [DOI: 10.1074/jbc.m400344200] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 376 |
Tang HJ, Qian D, Sondak VK, Stachura S, Lin J. A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin. Br J Cancer 2004;90:1285-92. [PMID: 15026814 DOI: 10.1038/sj.bjc.6601653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 377 |
Fernandez-Zapico ME, Bramati PS, Zakaria S, Kaczynski JA, Urrutia R. Fundamentals of transcription factors and their impact on pancreatic development and cancer. Pancreatology 2003;3:276-83. [PMID: 12890989 DOI: 10.1159/000071765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 378 |
O'Connell CD, Tully LA, Devaney JM, Marino MA, Jakupciak JP, Atha DH. Renewable standard reference material for the detection of TP53 mutations. Mol Diagn 2003;7:85-97. [PMID: 14580228 DOI: 10.1007/BF03260024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 379 |
Mitsumoto Y, Nakajima T, Marutani M, Kashiwazaki H, Moriguchi M, Kimura H, Okanoue T, Kagawa K, Tada M. Loss of p53 transcriptional activity in hepatocellular carcinoma evaluated by yeast-based functional assay: comparison with p53 immunohistochemistry. Human Pathology 2004;35:350-6. [DOI: 10.1016/j.humpath.2003.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 380 |
Bryant PJ. Towards the cellular functions of tumour suppressors. Trends Cell Biol 1993;3:31-5. [PMID: 14731715 DOI: 10.1016/0962-8924(93)90147-s] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 381 |
Ahn WS, Bae SM, Lee KH, Lee JM, Namkoong SE, Chun HJ, Kim CK, Kim Y. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Gynecologic Oncology 2004;92:611-21. [DOI: 10.1016/j.ygyno.2003.10.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 382 |
Pochylski T, Kwaśniewska A. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma. Eur J Obstet Gynecol Reprod Biol 2003;111:68-73. [PMID: 14557015 DOI: 10.1016/s0301-2115(03)00205-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 383 |
Okada T, Iizuka N, Yamada-Okabe H, Mori N, Tamesa T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T. Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma. FEBS Lett. 2003;555:583-590. [PMID: 14675778 DOI: 10.1016/s0014-5793(03)01345-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 384 |
Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004;108:196-9. [PMID: 14639602 DOI: 10.1002/ijc.11548] [Cited by in Crossref: 285] [Cited by in F6Publishing: 304] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 385 |
John Luo JC, Cheng TJ, Du CL, Wang JD. Molecular epidemiology of plasma oncoproteins in vinyl chloride monomer workers in Taiwan. Cancer Detect Prev 2003;27:94-101. [PMID: 12670519 DOI: 10.1016/s0361-090x(03)00021-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 386 |
Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC, Tseng TH. Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol. 2003;66:2281-2289. [PMID: 14637186 DOI: 10.1016/j.bcp.2003.07.014] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 387 |
Gdor Y, Timme TL, Kadmon D, Miles BJ, Thompson TC. Strategies for Prostate Cancer Gene Therapy. American Journal of Cancer 2004;3:79-95. [DOI: 10.2165/00024669-200403020-00002] [Reference Citation Analysis]
|
| 388 |
Keohavong P, Gao W, Zheng K, Mady H, Lan Q, Melhem M, Mumford J. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis. Analytical Biochemistry 2004;324:92-9. [DOI: 10.1016/j.ab.2003.09.030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 389 |
Hidalgo Grau LA, Badia JM, Salvador CA, Monsó TS, Canaleta JF, Nogués JM, Sala JS. Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers. HPB (Oxford) 2004;6:174-80. [PMID: 18333072 DOI: 10.1080/13651820410025110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 390 |
Bartram CR. Genetische Grundlagen der Kanzerogenese. Die Onkologie 2004. [DOI: 10.1007/978-3-662-06670-6_4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 391 |
Cheng T, Scadden DT. Cell Cycle Regulators in Stem Cells. Handbook of Stem Cells 2004. [DOI: 10.1016/b978-012436643-5/50096-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 392 |
Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest. 2003;21:744-757. [PMID: 14628433 DOI: 10.1081/cnv-120023773] [Cited by in Crossref: 275] [Cited by in F6Publishing: 284] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 393 |
Kanashiro CA, Schally AV, Groot K, Armatis P, Bernardino AL, Varga JL. Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin. Proc Natl Acad Sci USA. 2003;100:15836-15841. [PMID: 14660794 DOI: 10.1073/pnas.2536558100] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 394 |
Lee IS, Nishikawa A. Polyozellus multiplex, a Korean wild mushroom, as a potent chemopreventive agent against stomach cancer. Life Sci. 2003;73:3225-3234. [PMID: 14561527 DOI: 10.1016/j.lfs.2003.06.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 395 |
Jin S, Mazzacurati L, Zhu X, Tong T, Song Y, Shujuan S, Petrik KL, Rajasekaran B, Wu M, Zhan Q. Gadd45a contributes to p53 stabilization in response to DNA damage. Oncogene 2003;22:8536-40. [DOI: 10.1038/sj.onc.1206907] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 396 |
Zhang Q, Ni Q, Gan J, Shen Z, Luo J, Jin C, Zhang N, Zhang Y. p14ARF upregulation of p53 and enhanced effects of 5-fluorouracil in pancreatic cancer. Chin Med J (Engl). 2003;116:1150-1155. [PMID: 24008735 DOI: 10.1038/cddis.2013.307] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 397 |
Abid-essefi S, Baudrimont I, Hassen W, Ouanes Z, Mobio TA, Anane R, Creppy EE, Bacha H. DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by Vitamin E. Toxicology 2003;192:237-48. [DOI: 10.1016/s0300-483x(03)00329-9] [Cited by in Crossref: 163] [Cited by in F6Publishing: 151] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 398 |
Knillová J, Kolář Z. THE SIGNIFICANCE OF KEY REGULATORS OF APOPTOSIS IN THE DEVELOPMENT AND PROGNOSIS OF PROSTATE CARCINOMA. I. PROTEINS OF THE BCL-2 FAMILY AND PROTEIN P53. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003;147:3-10. [DOI: 10.5507/bp.2003.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 399 |
Kemp MQ, Jeffy BD, Romagnolo DF. Conjugated Linoleic Acid Inhibits Cell Proliferation through a p53-Dependent Mechanism: Effects on the Expression of G1-Restriction Points in Breast and Colon Cancer Cells. The Journal of Nutrition 2003;133:3670-7. [DOI: 10.1093/jn/133.11.3670] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 400 |
El-deiry WS. The role of p53 in chemosensitivity and radiosensitivity. Oncogene 2003;22:7486-95. [DOI: 10.1038/sj.onc.1206949] [Cited by in Crossref: 245] [Cited by in F6Publishing: 255] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 401 |
Shiraishi K, Kato S, Han SY, Liu W, Otsuka K, Sakayori M, Ishida T, Takeda M, Kanamaru R, Ohuchi N. Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library. J Biol Chem. 2004;279:348-355. [PMID: 14559903 DOI: 10.1074/jbc.m310815200] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 402 |
Bäumler C, Duan F, Onel K, Rapaport B, Jhanwar S, Offit K, Elkon KB. Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients. Leuk Res 2003;27:841-51. [PMID: 12804643 DOI: 10.1016/s0145-2126(03)00018-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 403 |
Burns TF, Fei P, Scata KA, Dicker DT, El-Deiry WS. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 2003;23:5556-71. [PMID: 12897130 DOI: 10.1128/MCB.23.16.5556-5571.2003] [Cited by in Crossref: 168] [Cited by in F6Publishing: 178] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 404 |
Russo SM, Ove R. Molecular targets as therapeutic strategies in the management of breast cancer. Expert Opin Ther Targets 2003;7:543-57. [PMID: 12885273 DOI: 10.1517/14728222.7.4.543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 405 |
Segev DL, Umbricht C, Zeiger MA. Molecular pathogenesis of thyroid cancer. Surg Oncol 2003;12:69-90. [PMID: 12946479 DOI: 10.1016/s0960-7404(03)00037-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 406 |
Burns TF, el-Deiry WS. Cell death signaling in maligancy. Cancer Treat Res 2003;115:319-43. [PMID: 12613203 DOI: 10.1007/0-306-48158-8_13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 407 |
Zhou J, Prives C. Replication of damaged DNA in vitro is blocked by p53. Nucleic Acids Res 2003;31:3881-92. [PMID: 12853603 DOI: 10.1093/nar/gkg468] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 408 |
Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A, Sirigu P. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003;87:864-6. [PMID: 12812887 DOI: 10.1136/bjo.87.7.864] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 409 |
Gottifredi V, Shieh SY, Prives C. Regulation of p53 after different forms of stress and at different cell cycle stages. Cold Spring Harb Symp Quant Biol 2000;65:483-8. [PMID: 12760065 DOI: 10.1101/sqb.2000.65.483] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 410 |
Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Cancer Chemother Pharmacol 2003;51:505-11. [PMID: 12709826 DOI: 10.1007/s00280-003-0614-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 411 |
Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer 2003;40:259-66. [PMID: 12781424 DOI: 10.1016/s0169-5002(03)00081-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 412 |
Liu G, Xia T, Chen X. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein. J Biol Chem 2003;278:17557-65. [PMID: 12609999 DOI: 10.1074/jbc.M210696200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 413 |
Nishikawa T, Salim EI, Morimura K, Kaneko M, Ogawa M, Kinoshita A, Osugi H, Kinoshita H, Fukushima S. High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine. Cancer Lett 2003;194:45-54. [PMID: 12706858 DOI: 10.1016/s0304-3835(03)00057-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 414 |
Frank SA. Somatic mutation: early cancer steps depend on tissue architecture. Curr Biol 2003;13:R261-3. [PMID: 12676101 DOI: 10.1016/s0960-9822(03)00195-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 415 |
Wang XL, Raveendran M, Wang J. Genetic influence on cigarette-induced cardiovascular disease. Prog Cardiovasc Dis 2003;45:361-82. [PMID: 12704594 DOI: 10.1053/pcad.2003.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 416 |
Zettler ME, Prociuk MA, Austria JA, Massaeli H, Zhong G, Pierce GN. OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am J Physiol Heart Circ Physiol 2003;284:H644-53. [PMID: 12529257 DOI: 10.1152/ajpheart.00494.2001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 417 |
Satoh T, Timme TL, Saika T, Ebara S, Yang G, Wang J, Ren C, Kusaka N, Mouraviev V, Thompson TC. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer. Hum Gene Ther 2003;14:91-101. [PMID: 12614561 DOI: 10.1089/104303403321070793] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 418 |
Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T. p53 Codon 72 polymorphism and urothelial cancer risk. Cancer Lett 2003;189:77-83. [PMID: 12445680 DOI: 10.1016/s0304-3835(02)00518-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 419 |
Baccouche S, Mabrouk I, Said S, Mosbah A, Jlidi R, Gargouri A. A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene. Cancer Lett 2003;189:91-6. [PMID: 12445682 DOI: 10.1016/s0304-3835(02)00405-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 420 |
Brandt BH. Genetische Diagnostik hereditärer Kolonkarzinome/Genetic Diagnostics for Hereditary Colon Cancer. LaboratoriumsMedizin 2003;27:114-121. [DOI: 10.1515/labmed.2003.017] [Reference Citation Analysis]
|
| 421 |
Pillai G, Roberts H, Gatter K, Pezzella F. p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems. Histopathology 2003;42:83-7. [PMID: 12493030 DOI: 10.1046/j.1365-2559.2003.01563.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 422 |
Wang Z. Animal Models for Mechanistic Cancer Research. Mechanisms in Carcinogenesis and Cancer Prevention 2003. [DOI: 10.1007/978-3-662-08602-5_15] [Reference Citation Analysis]
|
| 423 |
Guan XY, Sham JS, Tai LS, Fang Y, Li H, Liang Q. Evidence for another tumor suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma. Cancer Genet Cytogenet 2003;140:45-8. [PMID: 12550757 DOI: 10.1016/s0165-4608(02)00654-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 424 |
Blankenstein T, Qin Z. Chemical Carcinogens as Foreign Bodies and Some Pitfalls Regarding Cancer Immune Surveillance. Elsevier; 2003. pp. 179-207. [DOI: 10.1016/s0065-230x(03)90006-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 425 |
Yoshida W, Uzuki M, Kurose A, Yoshida M, Nishida J, Shimamura T, Sawai T. Cell characterization of mononuclear and giant cells constituting pigmented villonodular synovitis. Hum Pathol 2003;34:65-73. [PMID: 12605368 DOI: 10.1053/hupa.2003.52] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 426 |
Iyer R, Ding L, Batchu RB, Naugler S, Shammas MA, Munshi NC. Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma. Leuk Res 2003;27:73-8. [PMID: 12479855 DOI: 10.1016/s0145-2126(02)00064-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 427 |
De La Taille A, Vacherot F, Salomon L, Druel C, Gil Diez De Medina S, Abbou C, Buttyan R, Chopin D. Hormone-refractory prostate cancer: a multi-step and multi-event process. Prostate Cancer Prostatic Dis 2001;4:204-12. [PMID: 12497019 DOI: 10.1038/sj.pcan.4500534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 428 |
Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ. Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 2002;277:49676-84. [PMID: 12393870 DOI: 10.1074/jbc.M208756200] [Cited by in Crossref: 196] [Cited by in F6Publishing: 205] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 429 |
Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 2002;21:8486-97. [PMID: 12466968 DOI: 10.1038/sj.onc.1205946] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 430 |
Mumtaz MM, Tully DB, El-Masri HA, De Rosa CT. Gene induction studies and toxicity of chemical mixtures. Environ Health Perspect 2002;110 Suppl 6:947-56. [PMID: 12634124 DOI: 10.1289/ehp.02110s6947] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 431 |
Wu M, Putti TC, Bhuiya TA. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region. Appl Immunohistochem Mol Morphol 2002;10:351-6. [PMID: 12607604 DOI: 10.1097/00129039-200212000-00011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 432 |
Tchounwou P, Wilson B, Abdelghani A, Ishaque A, Patlolla A. Differential Cytotoxicity and Gene Expression in Human Liver Carcinoma (HepG2) Cells Exposed to Arsenic Trioxide, and Monosodium Acid Methanearsonate (MSMA). IJMS 2002;3:1117-32. [DOI: 10.3390/i3111117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 433 |
Lee B, Choi J, Kim J, Kim JH, Joo CH, Cho YK, Kim YK, Lee H. Oncolysis of human gastric cancers by an E1B 55 kDa-deleted YKL-1 adenovirus. Cancer Lett 2002;185:225-33. [PMID: 12169397 DOI: 10.1016/s0304-3835(02)00279-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 434 |
Yildirim S, Cermik H, Işitmangil T, Baloglu H, Gungor A, Pekkafali Z. Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma. J Int Med Res 2002;30:597-600. [PMID: 12526287 DOI: 10.1177/147323000203000608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 435 |
Kurtkaya-Yapicier O, Scheithauer BW, Hebrink D, James CD. p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study. Neurosurgery 2002;51:1246-54; discussion 1254-5. [PMID: 12383370 DOI: 10.1097/00006123-200211000-00021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 436 |
Klimov E, Vinokourova S, Moisjak E, Rakhmanaliev E, Kobseva V, Laimins L, Kisseljov F, Sulimova G. Human papilloma viruses and cervical tumours: mapping of integration sites and analysis of adjacent cellular sequences. BMC Cancer 2002;2:24. [PMID: 12377107 DOI: 10.1186/1471-2407-2-24] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 437 |
Søe K, Hartmann H, Schlott B, Stevnsner T, Grosse F. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro. Oncogene 2002;21:6614-23. [PMID: 12242659 DOI: 10.1038/sj.onc.1205912] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 438 |
Mao L. Recent advances in the molecular diagnosis of lung cancer. Oncogene 2002;21:6960-9. [PMID: 12362277 DOI: 10.1038/sj.onc.1205564] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 439 |
Huang YH, Wu JY, Zhang Y, Wu MX. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Oncogene 2002;21:6819-28. [PMID: 12360408 DOI: 10.1038/sj.onc.1205854] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 440 |
Asher G, Lotem J, Sachs L, Kahana C, Shaul Y. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A 2002;99:13125-30. [PMID: 12232053 DOI: 10.1073/pnas.202480499] [Cited by in Crossref: 169] [Cited by in F6Publishing: 177] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 441 |
Maeda S, Yoshida H, Mitsuno Y, Hirata Y, Ogura K, Shiratori Y, Omata M. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Mol Pathol 2002;55:286-93. [PMID: 12354930 DOI: 10.1136/mp.55.5.286] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 442 |
Buchholz TA, Wazer DE. Molecular biology and genetics of breast cancer development: a clinical perspective. Semin Radiat Oncol 2002;12:285-95. [PMID: 12382187 DOI: 10.1053/srao.2002.35248] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 443 |
Sutton D, Tchounwou P, Ninashvili N, Shen E. Mercury Induces Cytotoxicity and Transcriptionally Activates Stress Genes in Human Liver Carcinoma (HepG2) Cells. IJMS 2002;3:965-84. [DOI: 10.3390/i3090965] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 444 |
Shibata T, Nakata D, Chiba I, Yamashita T, Abiko Y, Tada M, Moriuchi T. Detection of TP53 mutation in ameloblastoma by the use of a yeast functional assay: Clonal TP53 mutation in ameloblastoma. Journal of Oral Pathology & Medicine 2002;31:534-8. [DOI: 10.1034/j.1600-0714.2002.00006.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 445 |
Toft NJ, Curtis LJ, Sansom OJ, Leitch AL, Wyllie AH, te Riele H, Arends MJ, Clarke AR. Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background. Oncogene 2002;21:6299-306. [PMID: 12214270 DOI: 10.1038/sj.onc.1205727] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 446 |
Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002;37:241-56. [PMID: 12234692 DOI: 10.1016/s0169-5002(02)00107-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 447 |
Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002;100:304-8. [PMID: 12115545 DOI: 10.1002/ijc.10483] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 448 |
Koul A, Bendahl PO, Borg A, Fernö M, Lidebring MF, Högberg T, Einarsson EL, Ridderheim M, Willén R. TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer. Int J Gynecol Cancer 2002;12:362-71. [PMID: 12144684 DOI: 10.1046/j.1525-1438.2002.01111.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 449 |
Lopes A, Bezerra ALR, Pinto CAL, Serrano SV, de Mello CA, Villa LL. p53 as a New Prognostic Factor for Lymph Node Metastasis in Penile Carcinoma: Analysis of 82 Patients Treated with Amputation and Bilateral Lymphadenectomy. Journal of Urology 2002;168:81-6. [DOI: 10.1016/s0022-5347(05)64836-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 450 |
Lopes A, Bezerra ALR, Pinto CAL, Serrano SV, de Mello CA, Villa LL. p53 as a New Prognostic Factor for Lymph Node Metastasis in Penile Carcinoma: Analysis of 82 Patients Treated with Amputation and Bilateral Lymphadenectomy: . The Journal of Urology. [DOI: 10.1097/00005392-200207000-00020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 451 |
Günzburg WH, Löhr M, Salmons B. Novel treatments and therapies in development for pancreatic cancer. Expert Opin Investig Drugs 2002;11:769-86. [PMID: 12036421 DOI: 10.1517/13543784.11.6.769] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 452 |
Zupanska A, Kaminska B. The diversity of p53 mutations among human brain tumors and their functional consequences. Neurochem Int 2002;40:637-45. [PMID: 11900859 DOI: 10.1016/s0197-0186(01)00114-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 453 |
Maeda S, Yoshida H, Mitsuno Y, Hirata Y, Ogura K, Shiratori Y, Omata M. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut 2002;50:771-8. [PMID: 12010877 DOI: 10.1136/gut.50.6.771] [Cited by in Crossref: 54] [Cited by in F6Publishing: 68] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 454 |
Ren C, Li L, Goltsov AA, Timme TL, Tahir SA, Wang J, Garza L, Chinault AC, Thompson TC. mRTVP-1, a novel p53 target gene with proapoptotic activities. Mol Cell Biol 2002;22:3345-57. [PMID: 11971968 DOI: 10.1128/MCB.22.10.3345-3357.2002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 455 |
Ma P, Magut M, Chen X, Chen CY. P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity. Mol Cell Biol 2002;22:2928-38. [PMID: 11940651 DOI: 10.1128/MCB.22.9.2928-2938.2002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 456 |
Xu M, Jin YL, Fu J, Huang H, Chen SZ, Qu P, Tian HM, Liu ZY, Zhang W. The abnormal expression of retinoic acid receptor-β, P53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. World J Gastroenterol 2002; 8(2): 200-202 [PMID: 11925591 DOI: 10.3748/wjg.v8.i2.200] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 457 |
Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Cancer 2002;94:2239-47. [PMID: 12001123 DOI: 10.1002/cncr.10450] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 458 |
Melle C, Nasheuer HP. Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase. Nucleic Acids Res 2002;30:1493-9. [PMID: 11917009 DOI: 10.1093/nar/30.7.1493] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 459 |
Sun Y, Cheung HS. p53, proto-oncogene and rheumatoid arthritis. Semin Arthritis Rheum 2002;31:299-310. [PMID: 11965594 DOI: 10.1053/sarh.2002.31550] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 460 |
Tanaka F, Takata T, Yamada T, Yanagihara K, Otake Y, Miyahara R, Nakagawa T, Kawano Y, Ishikawa S, Inui K, Wada H. Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer. Lung Cancer 2002;36:27-32. [PMID: 11891030 DOI: 10.1016/s0169-5002(01)00462-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 461 |
Rodrigo Tapia JP, González Meana MV, García González LA, Coto E, García Pedrero J, Núñez Batalla F, Suárez Nieto C. [Inactivation of p53 and amplification of cyclin D1 in squamous cell carcinomas of the head and neck]. Acta Otorrinolaringol Esp 2002;53:225-32. [PMID: 12185899 DOI: 10.1016/s0001-6519(02)78305-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 462 |
Funato T, Uehara S, Takahashi M, Kozawa K, Satoh J, Sasaki T, Kaku M. Microsatellite instability in gonadal tumors of XY pure gonadal dysgenesis patients. Int J Gynecol Cancer 2002;12:192-7. [PMID: 11975679 DOI: 10.1046/j.1525-1438.2002.01094.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 463 |
Kibbe MR, Li J, Nie S, Choi BM, Kovesdi I, Lizonova A, Billiar TR, Tzeng E. Potentiation of nitric oxide-induced apoptosis in p53-/- vascular smooth muscle cells. Am J Physiol Cell Physiol 2002;282:C625-34. [PMID: 11832348 DOI: 10.1152/ajpcell.00119.2001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 464 |
McDonald SP, Hoy WE, Maguire GP, Duarte NL, Wilcken DEL, Wang XL. The p53Pro72Arg polymorphism is associated with albuminuria among aboriginal Australians. J Am Soc Nephrol 2002;13:677-83. [PMID: 11856771 DOI: 10.1681/ASN.V133677] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 465 |
Tang MS, Pfeifer GP, Denissenko MF, Feng Z, Hu W, Pao A, Zheng Y, Zheng JB, Li H, Chen JX. Mapping polycyclic aromatic hydrocarbon and aromatic amine-induced DNA damage in cancer-related genes at the sequence level. Int J Hyg Environ Health 2002;205:103-13. [PMID: 12018002 DOI: 10.1078/1438-4639-00135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 466 |
Tchounwou PB, Wilson BA, Ishaque AB. Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem. 2001;222:49-59. [PMID: 11678611 DOI: 10.1023/A:1017903005541] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 467 |
Cortés-Canteli M, Pignatelli M, Santos A, Perez-Castillo A. CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J Biol Chem 2002;277:5460-7. [PMID: 11733516 DOI: 10.1074/jbc.M108761200] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 468 |
Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, Yang PC. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol 2002;20:900-10. [PMID: 11844810 DOI: 10.1200/JCO.2002.20.4.900] [Cited by in Crossref: 8] [Cited by in F6Publishing: 32] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 469 |
Martin LJ, Liu Z. Injury-induced spinal motor neuron apoptosis is preceded by DNA single-strand breaks and is p53- and Bax-dependent. J Neurobiol 2002;50:181-97. [PMID: 11810634 DOI: 10.1002/neu.10026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 86] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 470 |
Morrissey RE, Horvath C, Snyder EA, Patrick J, Collins N, Evans E, MacDonald JS. Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene. Toxicol Sci 2002;65:256-65. [PMID: 11812930 DOI: 10.1093/toxsci/65.2.256] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 471 |
Martin AC, Facchiano AM, Cuff AL, Hernandez-Boussard T, Olivier M, Hainaut P, Thornton JM. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein. Hum Mutat 2002;19:149-64. [PMID: 11793474 DOI: 10.1002/humu.10032] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 472 |
Brantley MA Jr, Worley L, Harbour JW. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy. Am J Ophthalmol 2002;133:242-8. [PMID: 11812429 DOI: 10.1016/s0002-9394(01)01362-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 473 |
Sanchez-Prieto R, Sanchez-Arevalo VJ, Servitja JM, Gutkind JS. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene 2002;21:974-9. [PMID: 11840343 DOI: 10.1038/sj.onc.1205134] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 474 |
Kuhn H, Liebers U, Gessner C, Karawajew L, Ruppert V, Schumacher A, Witt C, Wolff G. Infection of cells with replication deficient adenovirus induces cell cycle alterations and leads to downregulation of E2F-1. Biochim Biophys Acta 2002;1542:106-15. [PMID: 11853884 DOI: 10.1016/s0167-4889(01)00171-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 475 |
Henry H, Thomas A, Shen Y, White E. Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death. Oncogene 2002;21:748-60. [PMID: 11850803 DOI: 10.1038/sj.onc.1205125] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 476 |
Brajuskovic G, Marjanovic S, Skaro-milic A. In vivo monitoring of therapy-induced apoptotic process in patients with chronic lymphocytic leukemia and acute non-lymphoblastic leukemia. Arch Oncol 2002;10:55-60. [DOI: 10.2298/aoo0202055b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 477 |
Hennig W. Instabilität des Genoms: Transposons und Retroviren. Genetik 2002. [DOI: 10.1007/978-3-662-21953-9_15] [Reference Citation Analysis]
|
| 478 |
Houser S, Koshlatyi S, Lu T, Gopen T, Bargonetti J. Camptothecin and Zeocin can increase p53 levels during all cell cycle stages. Biochem Biophys Res Commun 2001;289:998-1009. [PMID: 11741290 DOI: 10.1006/bbrc.2001.6073] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 479 |
Weidman MK, Yalamanchili P, Ng B, Tsai W, Dasgupta A. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology 2001;291:260-71. [PMID: 11878895 DOI: 10.1006/viro.2001.1215] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 480 |
Shiozawa T, Shiohara S, Kanai M, Konishi I, Fujii S, Nikaido T. Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1). Cancer 2001;92:3005-11. [PMID: 11753978 DOI: 10.1002/1097-0142(20011215)92:12<3005::aid-cncr10153>3.0.co;2-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 481 |
Nasir L, Rutteman GR, Reid SW, Schulze C, Argyle DJ. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas. Cancer Lett 2001;174:83-9. [PMID: 11675155 DOI: 10.1016/s0304-3835(01)00637-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 482 |
Kumar JK, Kremsdorf R, Tabor S, Richardson CC. A Mutation in the gene-encoding bacteriophage T7 DNA polymerase that renders the phage temperature-sensitive. J Biol Chem 2001;276:46151-9. [PMID: 11551938 DOI: 10.1074/jbc.M106319200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 483 |
Behboudi A, Levan G, Hedrich HJ, Klinga-Levan K. High-density marker loss of heterozygosity analysis of rat chromosome 10 in endometrial adenocarcinoma. Genes Chromosomes Cancer 2001;32:330-41. [PMID: 11746974 DOI: 10.1002/gcc.1198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 484 |
Tiguert R, Bianco FJ, Oskanian P, Li Y, Grignon DJ, Wood DP, Pontes JE, Sarkar FH. STRUCTURAL ALTERATION OF p53 PROTEIN IN PATIENTS WITH MUSCLE INVASIVE BLADDER TRANSITIONAL CELL CARCINOMA. Journal of Urology 2001;166:2155-60. [DOI: 10.1016/s0022-5347(05)65525-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 485 |
Tiguert R, Bianco FJ, Oskanian P, Li Y, Grignon DJ, Wood DP, Pontes JE, Sarkar FH. STRUCTURAL ALTERATION OF p53 PROTEIN IN PATIENTS WITH MUSCLE INVASIVE BLADDER TRANSITIONAL CELL CARCINOMA. The Journal of Urology 2001. [DOI: 10.1097/00005392-200112000-00031] [Reference Citation Analysis]
|
| 486 |
Hollmann CA, Kittrell FS, Medina D, Butel JS. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Oncogene 2001;20:7645-57. [PMID: 11753642 DOI: 10.1038/sj.onc.1204980] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 487 |
Cobbs CS, Samanta M, Harkins LE, Gillespie GY, Merrick BA, MacMillan-Crow LA. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch Biochem Biophys 2001;394:167-72. [PMID: 11594730 DOI: 10.1006/abbi.2001.2540] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 488 |
Rodrigo Tapia JP, García González LA, Martínez Sánchez JA, González Meana MV, García Pedrero JM, Suárez Nieto C. [CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck]. Acta Otorrinolaringol Esp 2001;52:539-43. [PMID: 11692945 DOI: 10.1016/s0001-6519(01)78248-9] [Reference Citation Analysis]
|
| 489 |
Kaczanowski R, Trzeciak L, Kucharczyk K. Multitemperature single-strand conformation polymorphism. Electrophoresis 2001;22:3539-45. [PMID: 11669539 DOI: 10.1002/1522-2683(200109)22:16<3539::AID-ELPS3539>3.0.CO;2-T] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 490 |
Georgiou A, Gomatos IP, Ferekidis E, Syrigos K, Bistola V, Giotakis J, Adamopoulos G, Androulakis G. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma. Eur J Surg Oncol 2001;27:574-80. [PMID: 11520092 DOI: 10.1053/ejso.2001.1131] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 491 |
Hwang SG, Lee HC, Lee DW, Kim YS, Joo WH, Cho YK, Moon JY. Induction of apoptotic cell death by a p53-independent pathway in neuronal SK-N-MC cells after treatment with 2,2',5,5'-tetrachlorobiphenyl. Toxicology 2001;165:179-88. [PMID: 11522376 DOI: 10.1016/s0300-483x(01)00432-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 492 |
Senoo M, Matsumura Y, Habu S. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities. Biochem Biophys Res Commun 2001;286:628-34. [PMID: 11511106 DOI: 10.1006/bbrc.2001.5429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 493 |
Burns TF, Bernhard EJ, El-Deiry WS. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene 2001;20:4601-12. [PMID: 11498783 DOI: 10.1038/sj.onc.1204484] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 494 |
Perentesis JP, Sievers EL. Targeted therapies for high-risk acute myeloid leukemia. Hematol Oncol Clin North Am 2001;15:677-701, viii-ix. [PMID: 11676279 DOI: 10.1016/s0889-8588(05)70242-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 495 |
Huh NE, Pasumarthi KB, Soonpaa MH, Jing S, Patton B, Field LJ. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes. J Mol Cell Cardiol 2001;33:1405-19. [PMID: 11448130 DOI: 10.1006/jmcc.2001.1403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 496 |
Pettitt AR, Sherrington PD, Stewart G, Cawley JC, Taylor AM, Stankovic T. p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 2001;98:814-22. [PMID: 11468183 DOI: 10.1182/blood.v98.3.814] [Cited by in Crossref: 186] [Cited by in F6Publishing: 201] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 497 |
Pocard M, Debruyne P, Bras-Gonçalves R, Mareel M, Dutrillaux B, Poupon MF. Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer. Dis Colon Rectum 2001;44:1106-12. [PMID: 11535849 DOI: 10.1007/BF02234630] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 498 |
Tjalma WA, Weyler JJ, Bogers JJ, Pollefliet C, Baay M, Goovaerts GC, Vermorken JB, van Dam PA, van Marck EA, Buytaert PM. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2001;97:223-30. [PMID: 11451553 DOI: 10.1016/s0301-2115(00)00541-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 499 |
Aramli LA, Teschke CM. Alleviation of a defect in protein folding by increasing the rate of subunit assembly. J Biol Chem 2001;276:25372-7. [PMID: 11304542 DOI: 10.1074/jbc.M101759200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 500 |
Verbin S. GENETIC INFLUENCES IN WOMEN'S ORAL HEALTH. Dental Clinics of North America 2001;45:443-467. [DOI: 10.1016/s0011-8532(22)00536-5] [Reference Citation Analysis]
|
| 501 |
Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. J Pathol 2001;194:327-33. [PMID: 11439365 DOI: 10.1002/path.910] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 502 |
Chang F, Lai M. VARIOUS FORMS OF MUTANT p53 CONFER SENSITIVITY TO CISPLATIN AND DOXORUBICIN IN BLADDER CANCER CELLS. THE JOURNAL OF UROLOGY 2001. [DOI: 10.1097/00005392-200107000-00088] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 503 |
Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, Yamazaki K, Nakabayashi M, Ogihara T, Kaneda Y. Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001;38:48-55. [PMID: 11463759 DOI: 10.1161/01.hyp.38.1.48] [Cited by in Crossref: 177] [Cited by in F6Publishing: 185] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 504 |
Chang F, Lai M. VARIOUS FORMS OF MUTANT p53 CONFER SENSITIVITY TO CISPLATIN AND DOXORUBICIN IN BLADDER CANCER CELLS. Journal of Urology 2001;166:304-10. [DOI: 10.1016/s0022-5347(05)66150-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 505 |
Falk R. The Rise and Fall of Dominance. Biol Philos 2001;16:285-323. [DOI: 10.1023/a:1010611605295] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 506 |
Tchounwou PB, Wilson BA, Ishaque AB, Schneider J. Transcriptional activation of stress genes and cytotoxicity in human liver carcinoma cells (HepG2) exposed to 2,4,6-trinitrotoluene, 2,4-dinitrotoluene, and 2,6-dinitrotoluene. Environ Toxicol 2001;16:209-16. [PMID: 11409192 DOI: 10.1002/tox.1026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 507 |
Wang Z, Atencio J, Robinson ES, McCarrey JR. Ultraviolet B-induced melanoma in Monodelphis domestica occurs in the absence of alterations in the structure or expression of the p53 gene. Melanoma Res 2001;11:239-45. [PMID: 11468512 DOI: 10.1097/00008390-200106000-00005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 508 |
Martin LJ, Kaiser A, Yu JW, Natale JE, Al-Abdulla NA. Injury-induced apoptosis of neurons in adult brain is mediated by p53-dependent and p53-independent pathways and requires Bax. J Comp Neurol 2001;433:299-311. [PMID: 11298357 DOI: 10.1002/cne.1141] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 509 |
Tanaka F, Yanagihara K, Otake Y, Yamada T, Shoji T, Miyahara R, Inui K, Wada H. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 2001;19:555-61. [PMID: 11343930 DOI: 10.1016/s1010-7940(01)00670-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 510 |
Seiler F, Rehn B, Rehn S, Hermann M, Bruch J. Quartz exposure of the rat lung leads to a linear dose response in inflammation but not in oxidative DNA damage and mutagenicity. Am J Respir Cell Mol Biol 2001;24:492-8. [PMID: 11306444 DOI: 10.1165/ajrcmb.24.4.4181] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 511 |
Kawakami T, Soma Y, Mizoguchi M, Saito R. Overexpression of transforming growth factor-beta3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease. Int J Dermatol 2001;40:262-7. [PMID: 11454082 DOI: 10.1046/j.1365-4362.2001.01026.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 512 |
Chow V, Yuen AP, Lam KY, Ho WK, Wei WI. Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma. Head Neck 2001;23:286-91. [PMID: 11400229 DOI: 10.1002/hed.1032] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 513 |
Cho S, Hahm JH, Hong YS. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients. Br J Dermatol 2001;144:841-8. [PMID: 11298546 DOI: 10.1046/j.1365-2133.2001.04142.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 514 |
Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis. Oncogene 2001;20:1445-54. [PMID: 11313888 DOI: 10.1038/sj.onc.1204222] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 515 |
Olumi AF, Weidner N, Presti JC. p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma. Urol Oncol 2001;6:63-7. [PMID: 11166623 DOI: 10.1016/s1078-1439(00)00109-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 516 |
Lan Q, Feng Z, Tian D, He X, Rothman N, Tian L, Lu X, Terry MB, Mumford JL. p53 gene expression in relation to indoor exposure to unvented coal smoke in Xuan Wei, China. J Occup Environ Med 2001;43:226-30. [PMID: 11285870 DOI: 10.1097/00043764-200103000-00010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 517 |
Fan XQ, Guo YJ. Apoptosis in oncology. Cell Res 2001;11:1-7. [PMID: 11305320 DOI: 10.1038/sj.cr.7290060] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 518 |
Bánkfalvi A, Tory K, Kemper M, Breukelmann D, Cubick C, Poremba C, Füzesi L, Lellè RJ, Böcker W. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma. Pathol Res Pract 2000;196:489-501. [PMID: 10926327 DOI: 10.1016/S0344-0338(00)80051-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 519 |
Gao X, Honn KV. Recessive oncogenes: current status. Pathol Oncol Res 1995;1:7-22. [PMID: 11173562 DOI: 10.1007/BF02893578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 520 |
Seiler F, Rehn B, Rehn S, Bruchs J. Significant differences in the cellular and molecular reactions of rat and hamster lung after quartz exposure. Toxicol Lett 2001;119:11-9. [PMID: 11275417 DOI: 10.1016/s0378-4274(00)00289-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 521 |
Malkin D. The role of p53 in human cancer. J Neurooncol 2001;51:231-43. [PMID: 11407595 DOI: 10.1023/a:1010636426860] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 522 |
Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 2001;11:15-23. [PMID: 11243895 DOI: 10.1006/scbi.2000.0342] [Cited by in Crossref: 268] [Cited by in F6Publishing: 287] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 523 |
Shannon JA, Kefford RF, Mann GJ. Responses to ultraviolet-B in cell lines from hereditary melanoma kindreds. Melanoma Res 2001;11:1-9. [PMID: 11254110 DOI: 10.1097/00008390-200102000-00001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 524 |
Roels S, Tilmant K, Ducatelle R. p53 expression and apoptosis in melanomas of dogs and cats. Res Vet Sci 2001;70:19-25. [PMID: 11170847 DOI: 10.1053/rvsc.2000.0435] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 525 |
Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene 2001;20:320-8. [PMID: 11313961 DOI: 10.1038/sj.onc.1204080] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 526 |
D'Souza S, Xin H, Walter S, Choubey D. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J Biol Chem 2001;276:298-305. [PMID: 11013253 DOI: 10.1074/jbc.M007155200] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 527 |
Herbert BS, Wright AC, Passons CM, Wright WE, Ali IU, Kopelovich L, Shay JW. Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J Natl Cancer Inst 2001;93:39-45. [PMID: 11136840 DOI: 10.1093/jnci/93.1.39] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 528 |
Wang E, Marcotte R, Papaconstantinou HT, Papaconstantinou J. Commitment signalling for apoptosis, or DNA repair and its relevance to aging and age-dependent diseases. The Role of DNA Damage and Repair in Cell Aging 2001. [DOI: 10.1016/s1566-3124(01)04032-9] [Reference Citation Analysis]
|
| 529 |
López M, Anzola M, Cuevas-salazar N, Aguirre J, Martinez de Pancorbo M. p53, un gen supresor tumoral. Gaceta Médica de Bilbao 2001;98:21-7. [DOI: 10.1016/s0304-4858(01)74350-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 530 |
Tchounwou PB, Wilson BA, Ishaque AB, Schneider J. Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Molecular Mechanisms of Metal Toxicity and Carcinogenesis 2001. [DOI: 10.1007/978-1-4615-0793-2_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 531 |
Hussain SP, Harris CC. p53 Mutation Load. Biomonitors and Biomarkers as Indicators of Environmental Change 2 2001. [DOI: 10.1007/978-1-4615-1305-6_18] [Reference Citation Analysis]
|
| 532 |
Günzburg WH, Salmons B. Novel clinical strategies for the treatment of pancreatic carcinoma. Trends Mol Med 2001;7:30-7. [PMID: 11427987 DOI: 10.1016/s1471-4914(00)01865-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 533 |
Welton ML, Varma MG, Amerhauser A. Colon, Rectum, and Anus. Surgery 2001. [DOI: 10.1007/978-3-642-57282-1_33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 534 |
Ishikawa H, Mitsuhashi N, Sakurai H, Maebayashi K, Niibe H. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 2001;91:80-9. [PMID: 11148563 DOI: 10.1002/1097-0142(20010101)91:1<80::aid-cncr11>3.0.co;2-e] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 535 |
Kurita-Ochiai T, Ochiai K, Fukushima K. Butyric-acid-induced apoptosis in murine thymocytes and splenic T- and B-cells occurs in the absence of p53. J Dent Res 2000;79:1948-54. [PMID: 11201044 DOI: 10.1177/00220345000790120501] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 536 |
Liu Q, Gazitt Y. Adenovirus-mediated delivery of p53 results in substantial apoptosis to myeloma cells and is not cytotoxic to flow-sorted CD34(+) hematopoietic progenitor cells and normal lymphocytes. Exp Hematol 2000;28:1354-62. [PMID: 11146157 DOI: 10.1016/s0301-472x(00)00556-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 537 |
Tanaka F, Yanagihara K, Otake Y, Li M, Miyahara R, Wada H, Ito H. Biological features and preoperative evaluation of mediastinal nodal status in non-small cell lung cancer. Ann Thorac Surg 2000;70:1832-8. [PMID: 11156080 DOI: 10.1016/s0003-4975(00)01987-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 538 |
Martin LJ. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol Dis 2000;7:613-22. [PMID: 11114260 DOI: 10.1006/nbdi.2000.0314] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 539 |
Okura T, Nakamura M, Takata Y, Watanabe S, Kitami Y, Hiwada K. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells. Eur J Pharmacol 2000;407:227-35. [PMID: 11068018 DOI: 10.1016/s0014-2999(00)00758-5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 540 |
Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br J Cancer 2000;83:1380-6. [PMID: 11044365 DOI: 10.1054/bjoc.2000.1455] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 541 |
Sánchez-Fayos Calabuig P, Juzgado Lucas D, Bosch Esteva O, González Guirado A, Porres Cubero JC. [Colorectal cancer: inducing circumstances (etiology) and pathogenic paths (pathogenesis]. Rev Clin Esp 2000;200:605-16. [PMID: 11196590 DOI: 10.1016/s0014-2565(00)70019-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 542 |
Lee H, Kim J, Lee B, Chang JW, Ahn J, Park JO, Choi J, Yun CO, Kim BS, Kim JH. Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status. Int J Cancer 2000;88:454-63. [PMID: 11054676 DOI: 10.1002/1097-0215(20001101)88:3<454::aid-ijc19>3.0.co;2-t] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 543 |
Fan H, Eagan PA, Siddiqui HA, Gulley ML. Accumulation of p53 in infectious mononucleosis tissues. Human Pathology 2000;31:1397-403. [DOI: 10.1016/s0046-8177(00)80010-6] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 544 |
Sankaranarayanan K, Chakraborty R. Ionizing radiation and genetic risks. XII. The concept of "potential recoverability correction factor" (PRCF) and its use for predicting the risk of radiation-inducible genetic disease in human live births. Mutat Res 2000;453:129-81. [PMID: 11024484 DOI: 10.1016/s0027-5107(00)00107-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 545 |
Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, Mumtaz MM, Chapin RE. Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl Pharmacol 2000;168:79-90. [PMID: 11032763 DOI: 10.1006/taap.2000.9014] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 546 |
Zhang XW, Xu B. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells. Anticancer Drugs 2000;11:747-56. [PMID: 11129738 DOI: 10.1097/00001813-200010000-00012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 547 |
Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, Fojo T. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol 2000;2:709-17. [PMID: 11025661 DOI: 10.1038/35036335] [Cited by in Crossref: 282] [Cited by in F6Publishing: 291] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 548 |
Benoit V, Hellin AC, Huygen S, Gielen J, Bours V, Merville MP. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter. Oncogene 2000;19:4787-94. [PMID: 11032029 DOI: 10.1038/sj.onc.1203831] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 549 |
Borre M, Stausbol-Gron B, Overgaard J. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. J Urol. 2000;164:716-721. [PMID: 10953132 DOI: 10.1016/s0022-5347(05)67288-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 550 |
Borre M, Stausbol-Gron B, Overgaard J. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. J Urol 2000;164:716-21. [PMID: 10953132 DOI: 10.1097/00005392-200009010-00023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 551 |
Eastham JA, Grafton W, Martin CM, Williams BJ. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer. J Urol 2000;164:814-9. [PMID: 10953161 DOI: 10.1097/00005392-200009010-00055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 552 |
Taga M, Shiraishi K, Shimura T, Uematsu N, Kato T, Nishimune Y, Aizawa S, Oshimura M, Niwa O. The effect of caffeine on p53-dependent radioresponses in undifferentiated mouse embryonal carcinoma cells after X-ray and UV-irradiations. J Radiat Res 2000;41:227-41. [PMID: 11210826 DOI: 10.1269/jrr.41.227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 553 |
Eastham JA, Grafton W, Martin CM, Williams BJ. SUPPRESSION OF PRIMARY TUMOR GROWTH AND THE PROGRESSION TO METASTASIS WITH p53 ADENOVIRUS IN HUMAN PROSTATE CANCER. Journal of Urology 2000;164:814-9. [DOI: 10.1016/s0022-5347(05)67320-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 554 |
Henderson YC, Breau RL, Liu TJ, Clayman GL. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus. Head Neck. 2000;22:347-354. [PMID: 10862017 DOI: 10.1002/1097-0347(200007)22:4%3C347::AID-HED6%3E3.0.CO;2-J] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 555 |
Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Laryngoscope 2000;110:1339-45. [PMID: 10942137 DOI: 10.1097/00005537-200008000-00022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 556 |
Moos PJ, Edes K, Fitzpatrick FA. Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins. Proc Natl Acad Sci U S A 2000;97:9215-20. [PMID: 10908664 DOI: 10.1073/pnas.160241897] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 557 |
Gillet R, Grimber G, Bennoun M, Caron de Fromentel C, Briand P, Joulin V. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents. Oncogene 2000;19:3498-507. [PMID: 10918608 DOI: 10.1038/sj.onc.1203671] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 558 |
Chen ZY, Shie J, Tseng C. Up-regulation of gut-enriched krüppel-like factor by interferon-gamma in human colon carcinoma cells. FEBS Lett 2000;477:67-72. [PMID: 10899312 DOI: 10.1016/s0014-5793(00)01764-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 559 |
Henderson YC, Breau RL, Liu TJ, Clayman GL. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus. Head Neck 2000;22:347-54. [PMID: 10862017 DOI: 10.1002/1097-0347(200007)22:4<347::aid-hed6>3.0.co;2-j] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 560 |
Uberti D, Grilli M, Memo M. Contribution of NF-kappaB and p53 in the glutamate-induced apoptosis. Int J Dev Neurosci 2000;18:447-54. [PMID: 10817929 DOI: 10.1016/s0736-5748(00)00018-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 561 |
Honoki K, Tsujiuchi T, Tsutsumi M, Kido A, Morishita T, Yoshimoto M, Miyauchi Y, Mii Y, Tamai S, Konishi Y. Possible involvement of bcl-2 suppression in wild-type p53 gene-dependent cell growth repression in rat osteosarcoma cells. Toxicol Pathol 2000;28:575-9. [PMID: 10930045 DOI: 10.1177/019262330002800411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 562 |
Fernando SS, Wu X, Perera LS. p53 Overexpression and Steroid Hormone Receptor Status in Endometrial Carcinoma. Int J Surg Pathol 2000;8:213-22. [PMID: 11493992 DOI: 10.1177/106689690000800309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 563 |
Costa MJ, Hansen CL, Holden JA, Guinee D Jr. Topoisomerase II alpha: prognostic predictor and cell cycle marker in surface epithelial neoplasms of the ovary and peritoneum. Int J Gynecol Pathol 2000;19:248-57. [PMID: 10907174 DOI: 10.1097/00004347-200007000-00009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 564 |
Gallego MG, Aceñero MJ, Ortega S, Delgado AA, Cantero JL. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma. Dis Colon Rectum 2000;43:971-5. [PMID: 10910245 DOI: 10.1007/BF02237362] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 565 |
Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC, Klamut HJ. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000;275:20127-35. [PMID: 10777512 DOI: 10.1074/jbc.M909580199] [Cited by in Crossref: 209] [Cited by in F6Publishing: 217] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 566 |
van Rensburg EJ, Engelbrecht S, van Heerden WF, Kotze MJ, Raubenheimer EJ. Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample. Hum Mutat 1998;11:39-44. [PMID: 9450901 DOI: 10.1002/(SICI)1098-1004(1998)11:1<39::AID-HUMU6>3.0.CO;2-G] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 567 |
Tice RR, Furedi-Machacek M, Satterfield D, Udumudi A, Vasquez M, Dunnick JK. Measurement of micronucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene. Environ Mol Mutagen 1998;31:113-24. [PMID: 9544189 DOI: 10.1002/(sici)1098-2280(1998)31:2<113::aid-em3>3.0.co;2-n] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 568 |
Kwon Y, Shin BS, Chung IK. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis. J Biol Chem 2000;275:18503-10. [PMID: 10764786 DOI: 10.1074/jbc.M002081200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 569 |
Behnia M, Robertson KA, Martin WJ 2nd. Lung infections: role of apoptosis in host defense and pathogenesis of disease. Chest 2000;117:1771-7. [PMID: 10858414 DOI: 10.1378/chest.117.6.1771] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 570 |
Carnero A, Hudson JD, Hannon GJ, Beach DH. Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Res 2000;28:2234-41. [PMID: 10871344 DOI: 10.1093/nar/28.11.2234] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 571 |
Ko JL, Cheng YW, Chang SL, Su JM, Chen CY, Lee H. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer. Int J Cancer 2000;89:265-70. [PMID: 10861503 DOI: 10.1002/1097-0215(20000520)89:3<265::aid-ijc9>3.0.co;2-n] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 572 |
Mishra A, Doyle NA, Martin WJ 2cnd. Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. Am J Respir Cell Mol Biol 2000;22:543-9. [PMID: 10783125 DOI: 10.1165/ajrcmb.22.5.3851] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 573 |
Herrmann ME, Thompson K, Wojcik EM, Martinez R, Husain AN. Congenital sacrococcygeal teratomas: effect of gestational age on size, morphologic pattern, ploidy, p53, and ret expression. Pediatr Dev Pathol 2000;3:240-8. [PMID: 10742411 DOI: 10.1007/s100249910031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 574 |
Duncan MD, Tihan T, Donovan DM, Phung QH, Rowley DL, Harmon JW, Gearhart PJ, Duncan KL. Esophagogastric adenocarcinoma in an E1A/E1B transgenic model involves p53 disruption. J Gastrointest Surg 2000;4:290-7. [PMID: 10769092 DOI: 10.1016/s1091-255x(00)80078-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 575 |
Yoshimura C, Nomura S, Yamaoka M, Ohtani T, Matsuzakiz T, Yamaguchi K, Fukuharal S. Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer. Cancer Lett 2000;152:87-95. [PMID: 10754210 DOI: 10.1016/s0304-3835(99)00437-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 576 |
Sarlis NJ. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects. Rev Endocr Metab Disord 2000;1:183-96. [PMID: 11708296 DOI: 10.1023/a:1010079031162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 577 |
Matsumoto M, Natsugoe S, Nakashima S, Shimada M, Nakano S, Kusano C, Baba M, Takao S, Matsushita Y, Aikou T. Biological evaluation of undifferentiated carcinoma of the esophagus. Ann Surg Oncol 2000;7:204-9. [PMID: 10791851 DOI: 10.1007/BF02523655] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 578 |
Hussain SP, Harris CC. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat Res 2000;462:311-22. [PMID: 10767641 DOI: 10.1016/s1383-5742(00)00015-6] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 579 |
Zhang MN, Gong Y, Minuk GY. The effects of acute ethanol exposure on inhibitors of hepatic regenerative activity in the rat. Mol Cell Biochem 2000;207:109-14. [PMID: 10888235 DOI: 10.1023/a:1007014919003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 580 |
Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E, Michalas S. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 2000;77:129-36. [PMID: 10739702 DOI: 10.1006/gyno.1999.5715] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 581 |
Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, Demsky M, Fisher WW, Buchman A, Duyk G, Friedman L, Prives C, Kopczynski C. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 2000;101:91-101. [PMID: 10778859 DOI: 10.1016/S0092-8674(00)80626-1] [Cited by in Crossref: 312] [Cited by in F6Publishing: 330] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 582 |
Matsushita H, Morishita R, Aoki M, Tomita N, Taniyama Y, Nakagami H, Shimozato T, Higaki J, Kaneda Y, Ogihara T. Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells. Circulation 2000;101:1447-52. [PMID: 10736291 DOI: 10.1161/01.cir.101.12.1447] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 583 |
Friedman EA, Wang J. Digested fiber from wheat bran induces cdk inhibitors which block colon epithelial cells in G1. Adv Exp Med Biol 1999;470:65-76. [PMID: 10709675 DOI: 10.1007/978-1-4615-4149-3_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 584 |
Defavery R, Lemos JA, Kashima S, Bernardes JE, Scridelli CA, Covas DT, Tone LG. Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms' tumor. Sao Paulo Med J 2000;118:49-52. [PMID: 10772697 DOI: 10.1590/s1516-31802000000200005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 585 |
Hall MC, Li Y, Pong R, Ely B, Sagalowsky AI, Hsieh J. THE GROWTH INHIBITORY EFFECT OF p21 ADENOVIRUS ON HUMAN BLADDER CANCER CELLS. Journal of Urology 2000;163:1033-8. [DOI: 10.1016/s0022-5347(05)67877-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 586 |
Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 2000;21:461-7. [PMID: 10688866 DOI: 10.1093/carcin/21.3.461] [Cited by in Crossref: 418] [Cited by in F6Publishing: 435] [Article Influence: 18.2] [Reference Citation Analysis]
|
| 587 |
Herath NI, Kew MC, Whitehall VL, Walsh MD, Jass JR, Khanna KK, Young J, Powell LW, Leggett BA, Macdonald GA. p73 is up-regulated in a subset of hepatocellular carcinomas. Hepatology 2000;31:601-5. [PMID: 10706549 DOI: 10.1002/hep.510310309] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 588 |
Hall MC, Li Y, Pong R, Ely B, Sagalowsky AI, Hsieh &NA; J. THE GROWTH INHIBITORY EFFECT OF p21 ADENOVIRUS ON HUMAN BLADDER CANCER CELLS. The Journal of Urology 2000. [DOI: 10.1097/00005392-200003000-00092] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 589 |
Gicquel C, Bertherat J, Le Bouc Y, Bertagna X. Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinol Metab Clin North Am 2000;29:1-13, vii. [PMID: 10732260 DOI: 10.1016/s0889-8529(05)70112-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 590 |
Sung CJ, Zheng Y, Quddus MR, Kang X, Zhang ZF, Lauchlan SC, Zheng W. p53 as a significant prognostic marker in endometrial carcinoma. Int J Gynecol Cancer 2000;10:119-27. [PMID: 11240663 DOI: 10.1046/j.1525-1438.2000.00019.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 591 |
Higashiyama M, Miyoshi Y, Kodama K, Yokouchi H, Takami K, Nishijima M, Nakayama T, Kobayashi H, Minamigawa K, Nakamura Y. p53-regulated GML gene expression in non-small cell lung cancer. a promising relationship to cisplatin chemosensitivity. Eur J Cancer 2000;36:489-95. [PMID: 10717525 DOI: 10.1016/s0959-8049(99)00261-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 592 |
Choong P, Sim F. Tumours. Current Orthopaedics 2000;14:117-132. [DOI: 10.1054/cuor.1999.0070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 593 |
Blagosklonny MV, Robey R, Bates S, Fojo T. Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. J Clin Invest 2000;105:533-9. [PMID: 10683383 DOI: 10.1172/JCI8625] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 594 |
Müller H, Helin K. The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 2000;1470:M1-12. [PMID: 10656985 DOI: 10.1016/s0304-419x(99)00030-x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 119] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 595 |
Munsch D, Watanabe-Fukunaga R, Bourdon JC, Nagata S, May E, Yonish-Rouach E, Reisdorf P. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J Biol Chem 2000;275:3867-72. [PMID: 10660538 DOI: 10.1074/jbc.275.6.3867] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 596 |
Sheikh MS, Fornace AJ Jr. Role of p53 family members in apoptosis. J Cell Physiol 2000;182:171-81. [PMID: 10623880 DOI: 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3] [Cited by in Crossref: 140] [Cited by in F6Publishing: 143] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 597 |
Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000;84:212-6. [PMID: 10655200 DOI: 10.1136/bjo.84.2.212] [Cited by in Crossref: 78] [Cited by in F6Publishing: 102] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 598 |
Kew MC. Hepatocellular cancer. A century of progress. Clin Liver Dis 2000;4:257-68. [PMID: 11232189 DOI: 10.1016/s1089-3261(05)70107-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 599 |
Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000;26:29-52. [PMID: 10660490 DOI: 10.1053/ctrv.1999.0144] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 600 |
Bryś M, Semczuk A, Wójcik M, Krajewska WM, Jakowicki JA. p53 protein detection by the western blotting technique in normal and neoplastic specimens of human endometrium. Cancer Lett 2000;148:197-205. [PMID: 10695997 DOI: 10.1016/s0304-3835(99)00338-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 601 |
Vikhanskaya F, D'Incalci M, Broggini M. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. Nucleic Acids Res 2000;28:513-9. [PMID: 10606650 DOI: 10.1093/nar/28.2.513] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 602 |
Santucci MA, Barbieri E, Frezza G, Perrone A, Iacurti E, Galuppi A, Salvi F, Bunkeila F, Neri S, Putti C, Babini L. Radiation-induced gadd45 expression correlates with clinical response to radiotherapy of cervical carcinoma. Int J Radiat Oncol Biol Phys 2000;46:411-6. [PMID: 10661348 DOI: 10.1016/s0360-3016(99)00459-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 603 |
Kasper HU, Schneider-Stock R, Mellin W, Günther T, Roessner A. P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival. Pathol Res Pract 1999;195:815-20. [PMID: 10631716 DOI: 10.1016/S0344-0338(99)80103-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 604 |
De Miguel Rodríguez M, Galera Davidson H, Moyano Calvo J, Ortiz Gamiz A, Poyato Galán J, Sánchez Sánchez E, Blanco Palenciano E, Arribas Rodríguez J, Castiñeiras Fernández J. Determinación de ploidía de adn mediante citometría de flujo, índice ki-67 y sobreexpresión de proteína p53 en 121 carcinomas superficiales de vejiga t1. estudio retrospectivo correlación con las variables clásicas. Actas Urológicas Españolas 2000;24:785-95. [DOI: 10.1016/s0210-4806(00)72548-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 605 |
W?sierska-g?dek J, Bohrn E, Herceg Z, Wang Z, Wurzer G. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors. J Cell Biochem 2000;78:681-96. [DOI: 10.1002/1097-4644(20000915)78:4<681::aid-jcb17>3.0.co;2-d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 606 |
Nemunaitis J. Adenovirus Mediated p53 (Adp53) Gene Transfer. Transplantation in Hematology and Oncology 2000. [DOI: 10.1007/978-3-642-59592-9_36] [Reference Citation Analysis]
|
| 607 |
Elkas JC, Dorigo O, Berek JS. Intraperitoneal Biologic Therapy for Ovarian Cancer. Regional Chemotherapy 2000. [DOI: 10.1007/978-1-59259-219-7_12] [Reference Citation Analysis]
|
| 608 |
Tokino T, Nakamura Y. The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 2000;33:1-6. [PMID: 10714958 DOI: 10.1016/s1040-8428(99)00051-7] [Cited by in Crossref: 125] [Cited by in F6Publishing: 133] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 609 |
Holmdahl R. Rheumatoid arthritis viewed using a headache paradigm. Arthritis Res 2000;2:169-71. [PMID: 11094426 DOI: 10.1186/ar84] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 610 |
Hayashi S, Morishita R, Matsushita H, Nakagami H, Taniyama Y, Nakamura T, Aoki M, Yamamoto K, Higaki J, Ogihara T. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 2000;35:237-43. [PMID: 10642304 DOI: 10.1161/01.hyp.35.1.237] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 611 |
Harrington RE, Zhurkin VB, Durell SR, Jernigan RL, Nagaich AK, Appella E. A Structural Model for the P53 Complex with DNA Response Elements: Implications for P53 Function and Future Research Directions. Proteome and Protein Analysis 2000. [DOI: 10.1007/978-3-642-59631-5_19] [Reference Citation Analysis]
|
| 612 |
Fischer U, Rainov NG, Frank S, Steffens S, Heidmann O, Gorelow V, Burdach SEG, Kramm CM. Pharmacological Gene Therapy for Experimental Brain Tumors. Transplantation in Hematology and Oncology 2000. [DOI: 10.1007/978-3-642-59592-9_37] [Reference Citation Analysis]
|
| 613 |
Drexler HG, Fombonne S, Matsuo Y, Hu ZB, Hamaguchi H, Uphoff CC. p53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization? Leukemia 2000;14:198-206. [PMID: 10637496 DOI: 10.1038/sj.leu.2401604] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 614 |
Müller-Ladner U, Nishioka K. p53 in rheumatoid arthritis: friend or foe? Arthritis Res 2000;2:175-8. [PMID: 11094424 DOI: 10.1186/ar82] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 615 |
Lai SL, Perng RP, Hwang J. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci 2000;7:64-70. [PMID: 10644891 DOI: 10.1007/BF02255920] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 616 |
Figge J. Molecular Pathogenesis of Thyroid Cancer. In: Wartofsky L, editor. Thyroid Cancer. Totowa: Humana Press; 2000. pp. 57-75. [DOI: 10.1007/978-1-59259-199-2_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 617 |
Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmüller L, Deppert W. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 1999;18:7706-17. [PMID: 10618711 DOI: 10.1038/sj.onc.1202952] [Cited by in Crossref: 120] [Cited by in F6Publishing: 131] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 618 |
Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A 1999;96:14517-22. [PMID: 10588737 DOI: 10.1073/pnas.96.25.14517] [Cited by in Crossref: 343] [Cited by in F6Publishing: 363] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 619 |
Ananthaswamy HN, Ouhtit A, Evans RL, Gorny A, Khaskina P, Sands AT, Conti CJ. Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis. Oncogene 1999;18:7395-8. [PMID: 10602497 DOI: 10.1038/sj.onc.1203147] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 620 |
Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer 1999;35:1986-2002. [PMID: 10711241 DOI: 10.1016/s0959-8049(99)00298-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 112] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 621 |
Chan AO, Luk JM, Hui WM, Lam SK. Molecular biology of gastric carcinoma: from laboratory to bedside. J Gastroenterol Hepatol 1999;14:1150-60. [PMID: 10634150 DOI: 10.1046/j.1440-1746.1999.02000.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 622 |
Reynolds JC, Waronker M, Pacquing MS, Yassin RR. Barrett's esophagus. Reducing the risk of progression to adenocarcinoma. Gastroenterol Clin North Am 1999;28:917-45. [PMID: 10695010 DOI: 10.1016/s0889-8553(05)70098-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 623 |
Craanen ME, Blok P, Offerhaus GJ, Meijer GA, Dekker W, Kuipers EJ, Meuwissen SG. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999;189:481-6. [PMID: 10629547 DOI: 10.1002/(SICI)1096-9896(199912)189:4<481::AID-PATH482>3.0.CO;2-U] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 624 |
Wu GS, Burns TF, McDonald ER 3rd, Meng RD, Kao G, Muschel R, Yen T, el-Deiry WS. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. Oncogene 1999;18:6411-8. [PMID: 10597242 DOI: 10.1038/sj.onc.1203025] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 625 |
Burns TF, El-Deiry WS. The p53 pathway and apoptosis. J Cell Physiol 1999;181:231-9. [PMID: 10497302 DOI: 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L] [Cited by in Crossref: 161] [Cited by in F6Publishing: 163] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 626 |
Burns TF, El-deiry WS. The p53 pathway and apoptosis. J Cell Physiol 1999;181:231-9. [DOI: 10.1002/(sici)1097-4652(199911)181:2<231::aid-jcp5>3.0.co;2-l] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 627 |
Peralta EA, Liu X, Mccarty TM, Wilson TG, Diamond DJ, Ellenhorn JD. IMMUNOTHERAPY OF BLADDER CANCER TARGETING P53. Journal of Urology 1999;162:1806-11. [DOI: 10.1016/s0022-5347(05)68242-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 628 |
Peralta EA, Liu X, Mccarty TM, Wilson TG, Diamond DJ, Ellenhorn JDI. IMMUNOTHERAPY OF BLADDER CANCER TARGETING P53. The Journal of Urology 1999. [DOI: 10.1097/00005392-199911000-00074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 629 |
Einspahr JG, Alberts DS, Warneke JA, Bozzo P, Basye J, Grogan TM, Nelson MA, Bowden GT. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1999;1:468-75. [PMID: 10933063 DOI: 10.1038/sj.neo.7900061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 630 |
Ikeda G, Isaji S, Chandra B, Watanabe M, Kawarada Y. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 1999;86:1396-405. [PMID: 10526265 DOI: 10.1002/(sici)1097-0142(19991015)86:8<1396::aid-cncr3>3.0.co;2-h] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 631 |
Xaus J, Valledor AF, Cardó M, Marquès L, Beleta J, Palacios JM, Celada A. Adenosine Inhibits Macrophage Colony-Stimulating Factor-Dependent Proliferation of Macrophages Through the Induction of p27kip-1 Expression. The Journal of Immunology 1999;163:4140-4149. [DOI: 10.4049/jimmunol.163.8.4140] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 632 |
Dudenhöffer C, Kurth M, Janus F, Deppert W, Wiesmüller L. Dissociation of the recombination control and the sequence-specific transactivation function of P53. Oncogene 1999;18:5773-84. [PMID: 10523858 DOI: 10.1038/sj.onc.1202964] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 633 |
Tieu K, Zuo D, Yu P. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement of Bcl-2 and p53 proteins. J Neurosci Res 1999;58:426-35. [DOI: 10.1002/(sici)1097-4547(19991101)58:3<426::aid-jnr8>3.0.co;2-f] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 634 |
Kawakami T, Saito R, Takahashi K. Overexpression of p2lWaf1/Cip1 immunohistochemical staining in Bowen's disease, but not in disseminated superficial porokeratosis. Br J Dermatol 1999;141:647-51. [PMID: 10583111 DOI: 10.1046/j.1365-2133.1999.03102.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 635 |
Litvak DA, Papaconstantinou HT, Hwang KO, Kim M, Evers BM, Townsend CM. Inhibition of gastric cancer by camptothecin involves apoptosis and multiple cellular pathways. Surgery. 1999;126:223-230. [PMID: 10455888 DOI: 10.1016/S0039-6060(99)70159-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 636 |
Tanaka F, Kawano Y, Li M, Takata T, Miyahara R, Yanagihara K, Ohtake Y, Fukuse T, Wada H. Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer. J Clin Oncol 1999;17:2728-36. [PMID: 10561347 DOI: 10.1200/JCO.1999.17.9.2728] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 637 |
Marrogi AJ, Khan MA, Vonderheid EC, Wood GS, McBurney E. p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases. J Cutan Pathol 1999;26:369-78. [PMID: 10551408 DOI: 10.1111/j.1600-0560.1999.tb01860.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 638 |
Matherly LH, Taub JW. Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia. Leuk Lymphoma 1999;35:1-20. [PMID: 10512159 DOI: 10.3109/10428199909145701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 639 |
Huang C, Kohno N, Inufusa H, Kodama K, Taki T, Miyake M. Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53. Am J Pathol 1999;155:955-65. [PMID: 10487853 DOI: 10.1016/s0002-9440(10)65195-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 640 |
Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1999;45:309-14. [PMID: 10487550 DOI: 10.1016/s0360-3016(99)00188-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 641 |
Hale TK, Braithwaite AW. The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene. J Biol Chem 1999;274:23777-86. [PMID: 10446138 DOI: 10.1074/jbc.274.34.23777] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 642 |
Coomber DWJ, Hawkins NJ, Clark MA, Ward RL. Generation of Anti-p53 Fab Fragments from Individuals with Colorectal Cancer Using Phage Display. The Journal of Immunology 1999;163:2276-2283. [DOI: 10.4049/jimmunol.163.4.2276] [Reference Citation Analysis]
|
| 643 |
Okamoto K, Prives C. A role of cyclin G in the process of apoptosis. Oncogene 1999;18:4606-15. [PMID: 10467405 DOI: 10.1038/sj.onc.1202821] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 644 |
Sugikawa E, Yazaki N, Tsunoda S, Nakanishi N, Ohashi M. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53. Biochem Biophys Res Commun 1999;261:256-63. [PMID: 10425175 DOI: 10.1006/bbrc.1999.1019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 645 |
Codegoni AM, Bertoni F, Patregnani C, Marinetti E, D'Incalci M, Broggini M. Allelic expression of p73 in human ovarian cancers. Ann Oncol 1999;10:949-53. [PMID: 10509157 DOI: 10.1023/a:1008320609591] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 646 |
Song H, Conte JV Jr, Foster AH, McLaughlin JS, Wei C. Increased p53 protein expression in human failing myocardium. J Heart Lung Transplant 1999;18:744-9. [PMID: 10512520 DOI: 10.1016/s1053-2498(98)00039-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 647 |
Aoki M, Morishita R, Matsushita H, Hayashi S, Nakagami H, Yamamoto K, Moriguchi A, Kaneda Y, Higaki J, Ogihara T. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension 1999;34:192-200. [PMID: 10454440 DOI: 10.1161/01.hyp.34.2.192] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 648 |
Müller-Höcker J. Immunoreactivity of p53, Ki-67, and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland. Hum Pathol 1999;30:926-33. [PMID: 10452505 DOI: 10.1016/s0046-8177(99)90246-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 649 |
Lee M, Song H, Yu S, Lee K, Park J. A 40-kDa NF1-like protein, not YY1, binds to the rat p53 promoter for transactivation in various rat organs. Biochem Cell Biol 1999;77:209-14. [DOI: 10.1139/o99-033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 650 |
Hussain SP, Harris CC. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 1999;428:23-32. [PMID: 10517975 DOI: 10.1016/s1383-5742(99)00028-9] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 651 |
Tanyi J, Tory K, Bánkfalvi A, Shröder W, Rath W, Füzesi L. Analysis of p53 mutation and cyclin D1 expression in breast tumors. Pathol Oncol Res 1999;5:90-4. [PMID: 10393358 DOI: 10.1053/paor.1999.0201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 652 |
Kassim SK, Ali HS, Sallam MM, Fayed ST, Seada LS, abd-Elkawy E, Seada MA, Khalifa A. Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer. Clin Biochem 1999;32:333-8. [PMID: 10480447 DOI: 10.1016/s0009-9120(99)00026-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 653 |
Conejero C, Wright R, Freed W. Glutamate and antimitotic agents induce differentiation, p53 activation, and apoptosis in rodent neostriatal cell lines immortalized with the tsA58 allele of SV40 large T antigen. Exp Neurol 1999;158:109-20. [PMID: 10448422 DOI: 10.1006/exnr.1999.7083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 654 |
Scherr DS, Vaughan ED Jr, Wei J, Chung M, Felsen D, Allbright R, Knudsen BS. BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J Urol 1999;162:12-6; discussion 16-7. [PMID: 10379729 DOI: 10.1097/00005392-199907000-00003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 655 |
Wang DG. Apoptosis in neuroendocrine tumours. Clin Endocrinol (Oxf) 1999;51:1-9. [PMID: 10468958 DOI: 10.1046/j.1365-2265.1999.00756.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 656 |
Pfister C, Flaman JM, Dunet F, Grise P, Frebourg T. p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy. J Urol 1999;162:69-73. [PMID: 10379742 DOI: 10.1097/00005392-199907000-00017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 657 |
Ozaki I, Zern MA, Liu S, Wei DL, Pomerantz RJ, Duan L. Ribozyme-mediated specific gene replacement of the alpha1-antitrypsin gene in human hepatoma cells. J Hepatol 1999;31:53-60. [PMID: 10424283 DOI: 10.1016/s0168-8278(99)80163-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 658 |
Lowenfels AB, Maisonneuve P. Pancreatic cancer: development of a unifying etiologic concept. Ann N Y Acad Sci 1999;880:191-200. [PMID: 10415864 DOI: 10.1111/j.1749-6632.1999.tb09523.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 659 |
Pipkin JL, Hinson WG, James SJ, Shaddock JG, Lyn-Cook LE, Feuers RJ, Morris SM, Tolleson WH, Casciano DA. The relationship of p53 and stress proteins in response to bleomycin and retinoic acid in the p53 heterozygous mouse. Biochim Biophys Acta 1999;1450:164-76. [PMID: 10354508 DOI: 10.1016/s0167-4889(99)00044-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 660 |
Wang E. Age-dependent atrophy and microgravity travel: what do they have in common? FASEB J 1999;13 Suppl:S167-74. [PMID: 10352159 DOI: 10.1096/fasebj.13.9001.s167] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 661 |
Nawa G, Miyoshi Y, Yoshikawa H, Ochi T, Nakamura Y. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours. Br J Cancer 1999;80:1185-9. [PMID: 10376970 DOI: 10.1038/sj.bjc.6690484] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 662 |
Pfister C, Flaman JM, Martin C, Grise P, Frebourg T. SELECTIVE DETECTION OF INACTIVATING MUTATIONS OF THE TUMOR SUPPRESSOR GENE p53 IN BLADDER TUMORS. Journal of Urology 1999;161:1973-5. [DOI: 10.1016/s0022-5347(05)68866-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 663 |
Luo JC, Liu HT, Cheng TJ, Du CL, Wang JD. Plasma p53 protein and anti-p53 antibody expression in vinyl chloride monomer workers in Taiwan. J Occup Environ Med 1999;41:521-6. [PMID: 10390705 DOI: 10.1097/00043764-199906000-00020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 664 |
Costa MJ, Hansen CL, Walls JE, Scudder SA. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy. Hum Pathol 1999;30:640-7. [PMID: 10374771 DOI: 10.1016/s0046-8177(99)90088-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 665 |
O'Connell CD, Atha DH, Oldenburg MC, Tian J, Siebert M, Handrow R, Grooms K, Heisler L, de Arruda M. Detection of p53 gene mutations: analysis by single-strand conformation polymorphism and Cleavase fragment length polymorphism. Electrophoresis 1999;20:1211-23. [PMID: 10380761 DOI: 10.1002/(SICI)1522-2683(19990101)20:6<1211::AID-ELPS1211>3.0.CO;2-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 666 |
Kutach LS, Bolshakov S, Ananthaswamy HN. Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis. Electrophoresis 1999;20:1204-10. [PMID: 10380760 DOI: 10.1002/(SICI)1522-2683(19990101)20:6<1204::AID-ELPS1204>3.0.CO;2-S] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 667 |
Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999;18:3166-72. [PMID: 10340389 DOI: 10.1038/sj.onc.1202650] [Cited by in Crossref: 216] [Cited by in F6Publishing: 226] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 668 |
Augenlicht LH. The molecular genetics of colonic cancer. Cancer Treat Res 1998;98:351-82. [PMID: 10326675 DOI: 10.1007/978-1-4615-4977-2_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 669 |
Poulaki V, Benekou A, Bozas E, Bolaris S, Stylianopoulou F. p53 expression and regulation by NMDA receptors in the developing rat brain. J Neurosci Res 1999;56:427-40. [PMID: 10340750 DOI: 10.1002/(SICI)1097-4547(19990515)56:4<427::AID-JNR10>3.0.CO;2-J] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 670 |
Liu Y, Thor A, Shtivelman E, Cao Y, Tu G, Heath TD, Debs RJ. Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J Biol Chem 1999;274:13338-44. [PMID: 10224095 DOI: 10.1074/jbc.274.19.13338] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 671 |
Huang C, Ma WY, Maxiner A, Sun Y, Dong Z. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 1999;274:12229-35. [PMID: 10212189 DOI: 10.1074/jbc.274.18.12229] [Cited by in Crossref: 226] [Cited by in F6Publishing: 233] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 672 |
Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci U S A 1999;96:4592-7. [PMID: 10200307 DOI: 10.1073/pnas.96.8.4592] [Cited by in Crossref: 545] [Cited by in F6Publishing: 562] [Article Influence: 22.7] [Reference Citation Analysis]
|
| 673 |
Kelavkar UP, Badr KF. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene. Proc Natl Acad Sci U S A 1999;96:4378-83. [PMID: 10200270 DOI: 10.1073/pnas.96.8.4378] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 674 |
Argyle DJ. Gene therapy in veterinary medicine. Vet Rec 1999;144:369-76. [PMID: 10327537 DOI: 10.1136/vr.144.14.369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 675 |
Tanaka F, Yanagihara K, Ohtake Y, Miyahara R, Kawano Y, Fukuse T, Hitomi S, Wada H. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer. Jpn J Cancer Res 1999;90:432-8. [PMID: 10363582 DOI: 10.1111/j.1349-7006.1999.tb00766.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 676 |
Li L, Li J, Rao JN, Li M, Bass BL, Wang JY. Inhibition of polyamine synthesis induces p53 gene expression but not apoptosis. Am J Physiol 1999;276:C946-54. [PMID: 10199827 DOI: 10.1152/ajpcell.1999.276.4.C946] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 677 |
Weşierska-Gadek J, Bugajska-Schretter A, Löw-Baselli A, Grasl-Kraupp B. Cleavage of poly(ADP-ribose) transferase during p53-independent apoptosis in rat liver after treatment with N-nitrosomorpholine and cyproterone acetate. Mol Carcinog 1999;24:263-75. [PMID: 10326863 DOI: 10.1002/(sici)1098-2744(199904)24:4<263::aid-mc4>3.0.co;2-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 678 |
Kajiwara M, Toyoshima S, Yao T, Tanaka M, Tsuneyoshi M. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry. J Surg Oncol 1999;70:209-16. [PMID: 10219015 DOI: 10.1002/(sici)1096-9098(199904)70:4<209::aid-jso2>3.0.co;2-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 679 |
Morimura K, Yamamoto S, Murai T, Mori S, Chen TX, Wanibuchi H, Fukushima S. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Carcinogenesis 1999;20:715-8. [PMID: 10223204 DOI: 10.1093/carcin/20.4.715] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 680 |
Ju J, Pedersen-Lane J, Maley F, Chu E. Regulation of p53 expression by thymidylate synthase. Proc Natl Acad Sci U S A 1999;96:3769-74. [PMID: 10097112 DOI: 10.1073/pnas.96.7.3769] [Cited by in Crossref: 86] [Cited by in F6Publishing: 95] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 681 |
Froesch BA, Aimé-Sempé C, Leber B, Andrews D, Reed JC. Inhibition of p53 transcriptional activity by Bcl-2 requires its membrane-anchoring domain. J Biol Chem 1999;274:6469-75. [PMID: 10037739 DOI: 10.1074/jbc.274.10.6469] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 682 |
Janus F, Albrechtsen N, Knippschild U, Wiesmüller L, Grosse F, Deppert W. Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding. Mol Cell Biol 1999;19:2155-68. [PMID: 10022902 DOI: 10.1128/MCB.19.3.2155] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 683 |
Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999;29:697-702. [PMID: 10051470 DOI: 10.1002/hep.510290330] [Cited by in Crossref: 88] [Cited by in F6Publishing: 101] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 684 |
Ilyas M, Straub J, Tomlinson IP, Bodmer WF. Genetic pathways in colorectal and other cancers. Eur J Cancer 1999;35:335-51. [PMID: 10448282 DOI: 10.1016/s0959-8049(98)00431-6] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 685 |
Kruk PA, Bohr VA. Telomeric length in individuals and cell lines with altered p53 status. Radiat Oncol Investig 1999;7:13-21. [PMID: 10030619 DOI: 10.1002/(SICI)1520-6823(1999)7:1<13::AID-ROI2>3.0.CO;2-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 686 |
Scheinman M, Ascher E, Levi GS, Hingorani A, Shirazian D, Seth P. p53 gene transfer to the injured rat carotid artery decreases neointimal formation. J Vasc Surg 1999;29:360-9. [PMID: 9950994 DOI: 10.1016/s0741-5214(99)70389-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 687 |
Di Como CJ, Gaiddon C, Prives C. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol 1999;19:1438-49. [PMID: 9891077 DOI: 10.1128/MCB.19.2.1438] [Cited by in Crossref: 320] [Cited by in F6Publishing: 330] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 688 |
Prikhod'ko GG, Wang Y, Freulich E, Prives C, Miller LK. Baculovirus p33 binds human p53 and enhances p53-mediated apoptosis. J Virol 1999;73:1227-34. [PMID: 9882325 DOI: 10.1128/JVI.73.2.1227-1234.1999] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 689 |
van Driel WJ, Kenter GG, Fleuren GJ, Melief CJ, Trimbos BJ. Immunotherapeutic strategies for cervical squamous carcinoma. Hematol Oncol Clin North Am 1999;13:259-73. [PMID: 10080080 DOI: 10.1016/s0889-8588(05)70164-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 690 |
Chu E, Copur SM, Ju J, Chen TM, Khleif S, Voeller DM, Mizunuma N, Patel M, Maley GF, Maley F, Allegra CJ. Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex. Mol Cell Biol 1999;19:1582-94. [PMID: 9891091 DOI: 10.1128/MCB.19.2.1582] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 691 |
Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, Marsden PA. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 1999;274:3076-93. [PMID: 9915847 DOI: 10.1074/jbc.274.5.3076] [Cited by in Crossref: 157] [Cited by in F6Publishing: 160] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 692 |
Hieken TJ, Ronan SG, Farolan M, Shilkaitis AL, Das Gupta TK. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer 1999;85:375-82. [PMID: 10023705 DOI: 10.1002/(sici)1097-0142(19990115)85:2<375::aid-cncr15>3.0.co;2-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 693 |
Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol. 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1%3C36::AID-PATH150%3E3.0.CO;2-R] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 694 |
Zhan Q, Kontny U, Iglesias M, Alamo I Jr, Yu K, Hollander MC, Woodworth CD, Fornace AJ Jr. Inhibitory effect of Bcl-2 on p53-mediated transactivation following genotoxic stress. Oncogene 1999;18:297-304. [PMID: 9927186 DOI: 10.1038/sj.onc.1202310] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 695 |
Kraker AJ, Booher RN. Chapter 25. New Targets in Cell Cycle Regulation. Elsevier; 1999. pp. 247-56. [DOI: 10.1016/s0065-7743(08)60587-4] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 696 |
Luque EA, Tang LH, Bortecen KH, Kidd M, Miu K, Efstathiou JA, Modlin IM. Gastrin-regulated expression of p53 in transformed enterochromaffin-like cells in the African rodent mastomys. J Clin Gastroenterol 1998;27 Suppl 1:S116-24. [PMID: 9872508 DOI: 10.1097/00004836-199800001-00019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 697 |
Gao X, Honn KV. Chapter 5 Molecular biology of prostate cancer. The Oncobiology of the Prostate. Elsevier; 1999. pp. 85-122. [DOI: 10.1016/s1569-254x(99)80006-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 698 |
Elo JP, Härkönen P, Kyllönen AP, Lukkarinen O, Vihko P. Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient. Br J Cancer 1999;79:156-60. [PMID: 10408707 DOI: 10.1038/sj.bjc.6690025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 699 |
Koivisto PA, Rantala I. Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer. J Pathol 1999;187:237-41. [PMID: 10365100 DOI: 10.1002/(SICI)1096-9896(199901)187:2<237::AID-PATH224>3.0.CO;2-I] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 700 |
Sethi T. Gene Expression in Lung Cancer. Molecular Biology of the Lung 1999. [DOI: 10.1007/978-3-0348-8784-7_9] [Reference Citation Analysis]
|
| 701 |
Mccormick FC, Lemoine NR. Molecular Basis of Pancreatic Cancer: Strategies for Genetic Diagnosis and Therapy. Pancreatic Disease 1999. [DOI: 10.1007/978-1-4471-0801-6_26] [Reference Citation Analysis]
|
| 702 |
Werner H. Molecular Biology of the Type 1 IGF Receptor. In: Rosenfeld RG, Roberts CT, editors. The IGF System. Totowa: Humana Press; 1999. pp. 63-88. [DOI: 10.1007/978-1-59259-712-3_4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 703 |
Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Gagetti O, Bevilacqua G, Genazzani AR. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol 1999;72:76-81. [PMID: 9889034 DOI: 10.1006/gyno.1998.5101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 704 |
Srivastava S, Moul JW. Chapter 8 Molecular progression of prostate cancer. The Oncobiology of the Prostate 1999. [DOI: 10.1016/s1569-254x(99)80009-0] [Reference Citation Analysis]
|
| 705 |
Manne U, Weiss HL, Myers RB, Danner OK, Moron C, Srivastava S, Grizzle WE. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer 1998;83:2456-67. [PMID: 9874449 DOI: 10.1002/(sici)1097-0142(19981215)83:12<2456::aid-cncr8>3.0.co;2-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 706 |
Sturm PD, Baas IO, Clement MJ, Nakeeb A, Johan G, Offerhaus A, Hruban RH, Pitt HA. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. Int J Cancer 1998;78:695-8. [PMID: 9833761 DOI: 10.1002/(sici)1097-0215(19981209)78:6<695::aid-ijc5>3.0.co;2-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 707 |
Felgar RE, Steward KR, Cousar JB, Macon WR. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas. Am J Pathol 1998;153:1707-15. [PMID: 9846961 DOI: 10.1016/S0002-9440(10)65685-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 708 |
Johnson MI, Robinson MC, Marsh C, Robson CN, Neal DE, Hamdy FC. Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation. Prostate 1998;37:223-9. [PMID: 9831218 DOI: 10.1002/(sici)1097-0045(19981201)37:4<223::aid-pros3>3.0.co;2-o] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 709 |
Ham SJ, Schraffordt Koops H, van der Graaf WT, van Horn JR, Postma L, Hoekstra HJ. Historical, current and future aspects of osteosarcoma treatment. Eur J Surg Oncol 1998;24:584-600. [PMID: 9870738 DOI: 10.1016/s0748-7983(98)93896-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 710 |
Nalca A, Rangnekar VM. The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 function. J Biol Chem 1998;273:30517-23. [PMID: 9804820 DOI: 10.1074/jbc.273.46.30517] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 711 |
Will K, Warnecke G, Wiesmüller L, Deppert W. Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing. Proc Natl Acad Sci U S A 1998;95:13681-6. [PMID: 9811860 DOI: 10.1073/pnas.95.23.13681] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 712 |
Wagner HP. Cell cycle control and cancer. Indian J Pediatr 1998;65:805-14. [PMID: 10773944 DOI: 10.1007/BF02831338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 713 |
Mitomi H, Iwabuchi K, Amemiya A, Kaneda G, Adachi K, Asao T. Immunohistochemical analysis of a case of gastritis cystica profunda associated with carcinoma development. Scand J Gastroenterol 1998;33:1226-9. [PMID: 9867104 DOI: 10.1080/00365529850172610] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 714 |
Pang XP, Hershman JM. Transforming growth factor-beta1 resistance in a thyroid cancer model of tumor necrosis factor-alpha resistance. Thyroid 1998;8:1065-70. [PMID: 9848725 DOI: 10.1089/thy.1998.8.1065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 715 |
Liu Y, Riley LB, Bohn SA, Boice JA, Stadler PB, Sherley JL. Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions. J Cell Physiol 1998;177:364-76. [PMID: 9766533 DOI: 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 716 |
Lee M, Song H, Park S, Park J. Transcription of the rat p53 gene is mediated by factor binding to two recognition motifs of NF1-like protein. Biol Chem 1998;379:1333-40. [PMID: 9865606 DOI: 10.1515/bchm.1998.379.11.1333] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 717 |
Drews R, Kolker M, Moran C, Sachar D, Chan V, Schnipper L. Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions. Mutat Res 1998;421:9-25. [PMID: 9748479 DOI: 10.1016/s0027-5107(98)00149-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 718 |
Kubbutat MH, Ludwig RL, Ashcroft M, Vousden KH. Regulation of Mdm2-directed degradation by the C terminus of p53. Mol Cell Biol 1998;18:5690-8. [PMID: 9742086 DOI: 10.1128/MCB.18.10.5690] [Cited by in Crossref: 138] [Cited by in F6Publishing: 143] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 719 |
Lianidou ES, Angelopoulou K, Katsaros D, Durando A, Massobrio M, Diamandis EP. Fragment analysis of the p53 gene in ovarian tumors. Clin Biochem 1998;31:551-3. [PMID: 9812175 DOI: 10.1016/s0009-9120(98)00061-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 720 |
Murakawa Y, Yokoyama A, Kato S, Yoshioka T, Ichinohasama R, Kumabe T, Yoshimoto T, Ishioka C, Kanamaru R. Astrocytoma and B-cell lymphoma development in a man with a p53 germline mutation. Jpn J Clin Oncol 1998;28:631-7. [PMID: 9839505 DOI: 10.1093/jjco/28.10.631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 721 |
Mineta H, Borg A, Dictor M, Wahlberg P, Akervall J, Wennerberg J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 1998;78:1084-90. [PMID: 9792155 DOI: 10.1038/bjc.1998.632] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 722 |
Darnton SJ. Demystified ... p53. Mol Pathol 1998;51:248-53. [PMID: 10193518 DOI: 10.1136/mp.51.5.248] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 723 |
Bancher-Todesca D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair A, Heinze G, Breitenecker G, Hacker NF. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol 1998;71:59-63. [PMID: 9784320 DOI: 10.1006/gyno.1998.5113] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 724 |
Hollstein M, Moeckel G, Hergenhahn M, Spiegelhalder B, Keil M, Werle-Schneider G, Bartsch H, Brickmann J. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res 1998;405:145-54. [PMID: 9748548 DOI: 10.1016/s0027-5107(98)00131-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 725 |
Blok P, Craanen ME, Dekker W, Offerhaus GJ, Tytgat GN. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. J Pathol 1998;186:36-40. [PMID: 9875138 DOI: 10.1002/(SICI)1096-9896(199809)186:1<36::AID-PATH150>3.0.CO;2-R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 726 |
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-16. [PMID: 9774969 DOI: 10.1016/s1097-2765(00)80275-0] [Cited by in Crossref: 1569] [Cited by in F6Publishing: 1642] [Article Influence: 62.8] [Reference Citation Analysis]
|
| 727 |
Dudenhöffer C, Rohaly G, Will K, Deppert W, Wiesmüller L. Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol 1998;18:5332-42. [PMID: 9710617 DOI: 10.1128/MCB.18.9.5332] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 728 |
Iniesta P, Vega FJ, Caldés T, Massa M, de Juan C, Cerdán FJ, Sánchez A, López JA, Torres AJ, Balibrea JL, Benito M. p53 exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer. Cancer Lett 1998;130:153-60. [PMID: 9751268 DOI: 10.1016/s0304-3835(98)00138-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 729 |
Drach J, Ackermann J, Fritz E, Krömer E, Schuster R, Gisslinger H, Desantis M, Zojer N, Fiegl M, Roka S, Schuster J, Heinz R, Ludwig H, Huber H. Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy. Blood 1998;92:802-9. [DOI: 10.1182/blood.v92.3.802.415a17_802_809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [ |
